KR102532929B1 - Composition for skin cosmetics - Google Patents
Composition for skin cosmetics Download PDFInfo
- Publication number
- KR102532929B1 KR102532929B1 KR1020207037364A KR20207037364A KR102532929B1 KR 102532929 B1 KR102532929 B1 KR 102532929B1 KR 1020207037364 A KR1020207037364 A KR 1020207037364A KR 20207037364 A KR20207037364 A KR 20207037364A KR 102532929 B1 KR102532929 B1 KR 102532929B1
- Authority
- KR
- South Korea
- Prior art keywords
- component
- mass
- oil
- composition
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 145
- 239000000203 mixture Substances 0.000 title claims abstract description 126
- -1 Polyoxyethylene Polymers 0.000 claims abstract description 60
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 48
- 239000003921 oil Substances 0.000 claims abstract description 40
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 28
- 125000006353 oxyethylene group Chemical group 0.000 claims abstract description 27
- 229930182558 Sterol Natural products 0.000 claims abstract description 24
- 235000003702 sterols Nutrition 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000004359 castor oil Substances 0.000 claims abstract description 20
- 235000019438 castor oil Nutrition 0.000 claims abstract description 20
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 20
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 20
- 150000003432 sterols Chemical class 0.000 claims abstract description 19
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 17
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 10
- 239000004615 ingredient Substances 0.000 claims abstract description 10
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 9
- 229940058015 1,3-butylene glycol Drugs 0.000 claims abstract description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 8
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims abstract description 7
- 150000002170 ethers Chemical class 0.000 claims abstract description 7
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 9
- 238000003860 storage Methods 0.000 abstract description 38
- 235000019198 oils Nutrition 0.000 description 37
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 14
- 239000000232 Lipid Bilayer Substances 0.000 description 12
- 239000012528 membrane Substances 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 239000006210 lotion Substances 0.000 description 11
- 239000000693 micelle Substances 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000002502 liposome Substances 0.000 description 10
- 229920001296 polysiloxane Polymers 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 8
- 239000003974 emollient agent Substances 0.000 description 8
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 7
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 7
- 229940032094 squalane Drugs 0.000 description 7
- 230000006641 stabilisation Effects 0.000 description 7
- 238000011105 stabilization Methods 0.000 description 7
- 235000021355 Stearic acid Nutrition 0.000 description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 6
- 239000008117 stearic acid Substances 0.000 description 6
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 5
- 240000000912 Macadamia tetraphylla Species 0.000 description 5
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 5
- 229920002545 silicone oil Polymers 0.000 description 5
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 235000019482 Palm oil Nutrition 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 229960001631 carbomer Drugs 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 4
- 229940049964 oleate Drugs 0.000 description 4
- 239000002540 palm oil Substances 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 210000004761 scalp Anatomy 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 3
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 3
- 241001135917 Vitellaria paradoxa Species 0.000 description 3
- 239000001361 adipic acid Substances 0.000 description 3
- 235000011037 adipic acid Nutrition 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 3
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 3
- 229940113124 polysorbate 60 Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 2
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- CAYHVMBQBLYQMT-UHFFFAOYSA-N 2-decyltetradecan-1-ol Chemical compound CCCCCCCCCCCCC(CO)CCCCCCCCCC CAYHVMBQBLYQMT-UHFFFAOYSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229940049654 glyceryl behenate Drugs 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229940072106 hydroxystearate Drugs 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940042880 natural phospholipid Drugs 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229940068065 phytosterols Drugs 0.000 description 2
- 235000002378 plant sterols Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000010667 rosehip oil Substances 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 description 1
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
- IJFVSSZAOYLHEE-SSEXGKCCSA-N 1,2-dilauroyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC IJFVSSZAOYLHEE-SSEXGKCCSA-N 0.000 description 1
- SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 1
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- LBPNCQGSZHRGME-UHFFFAOYSA-N 2,2,3,3,4,4-hexahydroxyoctadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)(O)C(O)(O)C(O)(O)C(O)=O LBPNCQGSZHRGME-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- KIOWXTOCDZJCBM-UHFFFAOYSA-N 2-docosoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KIOWXTOCDZJCBM-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- YHCCCMIWRBJYHG-UHFFFAOYSA-N 3-(2-ethylhexoxymethyl)heptane Chemical compound CCCCC(CC)COCC(CC)CCCC YHCCCMIWRBJYHG-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CQSRUKJFZKVYCY-UHFFFAOYSA-N 5alpha-isofucostan-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 CQSRUKJFZKVYCY-UHFFFAOYSA-N 0.000 description 1
- COJADMTVMJHMNE-UHFFFAOYSA-N 6,6-diethyloctanoic acid Chemical compound CCC(CC)(CC)CCCCC(O)=O COJADMTVMJHMNE-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 244000136475 Aleurites moluccana Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- GBBBJSKVBYJMBG-QTWVXCTBSA-N Fucosterol Natural products CC=C(CC[C@@H](C)[C@@H]1CC[C@@H]2[C@H]3C=C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C)C(C)C GBBBJSKVBYJMBG-QTWVXCTBSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- OSELKOCHBMDKEJ-VRUYXKNBSA-N Isofucosterol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C OSELKOCHBMDKEJ-VRUYXKNBSA-N 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000144217 Limnanthes alba Species 0.000 description 1
- 229920000433 Lyocell Polymers 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920002642 Polysorbate 65 Polymers 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 240000004978 Rosa x damascena Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 239000004163 Spermaceti wax Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000010478 argan oil Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940110830 beheneth-25 methacrylate Drugs 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 1
- 235000004420 brassicasterol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960003724 dimyristoylphosphatidylcholine Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- OSELKOCHBMDKEJ-JUGJNGJRSA-N fucosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]1(C)CC2 OSELKOCHBMDKEJ-JUGJNGJRSA-N 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 210000000474 heel Anatomy 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 239000008350 hydrogenated phosphatidyl choline Substances 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- KCYQMQGPYWZZNJ-BQYQJAHWSA-N hydron;2-[(e)-oct-1-enyl]butanedioate Chemical compound CCCCCC\C=C\C(C(O)=O)CC(O)=O KCYQMQGPYWZZNJ-BQYQJAHWSA-N 0.000 description 1
- 229940031575 hydroxyethyl urea Drugs 0.000 description 1
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229920002601 oligoester Polymers 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 150000008106 phosphatidylserines Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 1
- 239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 1
- 235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 1
- 229940099511 polysorbate 65 Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- 239000001228 rosa centifolia flower Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019385 spermaceti wax Nutrition 0.000 description 1
- GHIZCSMTYWOBQA-BZSCQJQFSA-N spinasterol Natural products CC[C@H](C=C[C@@H](C)[C@@H]1CC[C@@]2(C)C3=CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C GHIZCSMTYWOBQA-BZSCQJQFSA-N 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 125000002328 sterol group Chemical group 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 125000005063 tetradecenyl group Chemical group C(=CCCCCCCCCCCCC)* 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 유분을 비교적 다량으로 포함할 수 있고, 또한 투명성 및 보존 안정성이 뛰어난 피부 화장료용 조성물을 제공한다.
하기 성분 A와, 하기 성분 B와, 하기 성분 C와, 하기 성분 D와, 하기 성분 E와, 하기 성분 F와, 하기 성분 G와, 하기 성분 H를 함유하고, 상기 성분 A에 대한 상기 성분 B의 질량비(B/A)가 5.5∼18.0인 피부 화장료용 조성물:
성분 A: 인지질
성분 B: 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스테롤 에테르 및/또는 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스타놀 에테르
성분 C: 분기쇄를 갖는 탄소수 12∼24의 1가의 지방족 알코올
성분 D: 프로필렌 글리콜, 디프로필렌 글리콜 및 1,3-부틸렌 글리콜로 이루어지는 군으로부터 선택된 1종 이상의 다가 알코올
성분 E: 물
성분 F: 스테롤
성분 G: 유분
성분 H: 옥시에틸렌의 평균 부가 몰수가 5∼30인 폴리옥시에틸렌 경화 피마자유.The present invention provides a composition for skin cosmetics that can contain a relatively large amount of oil and has excellent transparency and storage stability.
Component A below, component B below, component C below, component D below, component E below, component F below, component G below, component H below, and component B relative to component A. A composition for skin cosmetics having a mass ratio (B/A) of 5.5 to 18.0:
Component A: Phospholipids
Component B: Polyoxyethylene sterol ethers having an average added mole number of oxyethylene of 15 to 50 and/or polyoxyethylene stanol ethers having an average added mole number of oxyethylene of 15 to 50
Component C: branched chain monohydric aliphatic alcohol having 12 to 24 carbon atoms
Component D: at least one polyhydric alcohol selected from the group consisting of propylene glycol, dipropylene glycol and 1,3-butylene glycol
Ingredient E: Water
Ingredient F: Sterol
Ingredient G: Oil
Component H: Polyoxyethylene hydrogenated castor oil having an average added mole number of oxyethylene of 5 to 30.
Description
본 발명은 피부 화장료용 조성물에 관한 것이다. 보다 상세하게는, 유분을 함유하는 수계(水系)의 피부 화장료용 조성물에 관한 것이다.The present invention relates to a composition for skin cosmetics. More specifically, it relates to a water-based skin cosmetic composition containing oil.
종래, 피부의 수분의 증산을 막아, 각질을 유연하게 하는 등 에몰리언트 효과가 있어, 보습성에 기여하는 점에서, 유분을 수계 화장료에 배합하는 것이 시도되고 있다. 수계 화장료에, 물에 난용성인 유분을 배합하기 위한 기술로서, 미셀에 의한 가용화(예를 들면, 특허문헌 1)나, 캐리어로서 리포솜(폐쇄 소포체)(예를 들면, 특허문헌 2)을 이용하는 기술 등이 알려져 있다.Conventionally, there is an emollient effect, such as preventing evaporation of water in the skin and softening keratin, and thus contributing to moisturizing properties, and it has been attempted to incorporate oil into water-based cosmetics. As a technology for blending water-insoluble oil into water-based cosmetics, solubilization by micelles (e.g., Patent Document 1) and technology using liposomes (closed vesicles) as carriers (e.g., Patent Document 2) etc. are known.
그러나, 에몰리언트 효과를 발휘할 정도의 양의 유분을 배합한 투명한 수계 화장료를 조제하는 것은 극히 곤란했다. 예를 들면, 비이온 계면활성제로 미셀을 형성하는 경우, 미셀의 크기는 통상 10∼20nm 정도로 매우 작아서, 미셀 내에 유분을 도입할 스페이스가 충분하지 않아, 배합할 수 있는 유분의 양은 한정적이 된다. 이 때문에, 외관이 투명한 수계 화장료가 얻어지기는 하지만, 충분한 에몰리언트 효과가 얻어진다고는 말하기 어렵다.However, it has been extremely difficult to prepare a transparent water-based cosmetic containing oil in an amount sufficient to exert an emollient effect. For example, when micelles are formed with a nonionic surfactant, the size of the micelles is usually very small, about 10 to 20 nm, and there is not enough space to introduce oil into the micelles, so the amount of oil that can be blended becomes limited. For this reason, although a water-based cosmetic composition with a transparent appearance is obtained, it is difficult to say that a sufficient emollient effect is obtained.
또, 리포솜에 의해 유분을 배합하는 기술에도 문제가 있다. 리포솜은 100nm 오더의 사이즈로, 미셀보다도 커서, 리포솜막 내에 유분을 보다 많이 배합할 수 있다. 그러나, 리포솜의 입경(粒徑)에 의존하여 투명성은 저하하고, 특히, 저(低)점도의 로션제형에 배합한 경우는, 보존 안정성이 뒤떨어진다.In addition, there is also a problem with the technique of blending oil with liposomes. Liposomes are on the order of 100 nm in size and are larger than micelles, so that more oil can be blended into the liposome membrane. However, the transparency decreases depending on the particle size of the liposome, and in particular, when formulated into a low-viscosity lotion formulation, the storage stability is poor.
따라서, 본 발명의 목적은, 유분을 비교적 다량으로 포함할 수 있고, 또한 투명성 및 보존 안정성이 뛰어난 피부 화장료용 조성물을 제공하는 것에 있다.Accordingly, an object of the present invention is to provide a composition for skin cosmetics that can contain a relatively large amount of oil and is excellent in transparency and storage stability.
본 발명자는, 상기 목적을 달성하기 위해 예의 검토한 결과, 인지질과, 특정의 폴리옥시에틸렌 스테롤 에테르 및/또는 특정의 폴리옥시에틸렌 스타놀 에테르와, 특정의 지방족 알코올과, 특정의 다가 알코올과, 물과, 스테롤과, 유분과, 특정의 폴리옥시에틸렌 경화 피마자유를 함유하고, 인지질과, 특정의 폴리옥시에틸렌 스테롤 에테르 및/또는 특정의 폴리옥시에틸렌 스타놀 에테르를 특정의 질량비로 하는 수계의 피부 화장료용 조성물에 의하면, 유분을 비교적 다량으로 포함할 수 있고, 또한 투명성 및 보존 안정성이 뛰어난 피부 화장료용 조성물이 얻어지는 것을 발견했다. 본 발명은 이들의 지견에 의거하여 완성시킨 것이다.As a result of intensive studies to achieve the above object, the present inventors have found that phospholipids, specific polyoxyethylene sterol ethers and/or specific polyoxyethylene stanol ethers, specific aliphatic alcohols, specific polyhydric alcohols, An aqueous system containing water, a sterol, an oil component, a specific polyoxyethylene hydrogenated castor oil, and a phospholipid, a specific polyoxyethylene sterol ether and/or a specific polyoxyethylene stanol ether in a specific mass ratio. According to the composition for skin cosmetics, it was found that a composition for skin cosmetics that could contain a relatively large amount of oil and was excellent in transparency and storage stability was obtained. This invention was completed based on these knowledge.
즉, 본 발명은, 하기 성분 A와, 하기 성분 B와, 하기 성분 C와, 하기 성분 D와, 하기 성분 E와, 하기 성분 F와, 하기 성분 G와, 하기 성분 H를 함유하고, 상기 성분 A에 대한 상기 성분 B의 질량비(B/A)가 5.5∼18.0인 피부 화장료용 조성물을 제공한다.That is, the present invention contains the following component A, the following component B, the following component C, the following component D, the following component E, the following component F, the following component G, and the following component H, Provided is a composition for skin cosmetics in which the mass ratio (B/A) of the component B to A is 5.5 to 18.0.
성분 A: 인지질Component A: Phospholipids
성분 B: 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스테롤 에테르 및/또는 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스타놀 에테르Component B: Polyoxyethylene sterol ethers having an average added mole number of oxyethylene of 15 to 50 and/or polyoxyethylene stanol ethers having an average added mole number of oxyethylene of 15 to 50
성분 C: 분기쇄를 갖는 탄소수 12∼24의 1가의 지방족 알코올Component C: branched chain monohydric aliphatic alcohol having 12 to 24 carbon atoms
성분 D: 프로필렌 글리콜, 디프로필렌 글리콜 및 1,3-부틸렌 글리콜로 이루어지는 군으로부터 선택된 1종 이상의 다가 알코올Component D: at least one polyhydric alcohol selected from the group consisting of propylene glycol, dipropylene glycol and 1,3-butylene glycol
성분 E: 물Ingredient E: Water
성분 F: 스테롤Ingredient F: Sterol
성분 G: 유분Ingredient G: Oil
성분 H: 옥시에틸렌의 평균 부가 몰수가 5∼30인 폴리옥시에틸렌 경화 피마자유.Component H: Polyoxyethylene hydrogenated castor oil having an average added mole number of oxyethylene of 5 to 30.
상기 피부 화장료용 조성물은, 하기 성분 I를 추가로 함유하는 것이 바람직하다.It is preferable that the said composition for skin cosmetics further contains the following component I.
성분 I: 글리세린 모노2-에틸헥실 에테르.Component I: Glycerin mono2-ethylhexyl ether.
상기 피부 화장료용 조성물은, 하기 성분 J를 추가로 함유하는 것이 바람직하다.It is preferable that the said composition for skin cosmetics further contains the following component J.
성분 J: 탄소수 5∼10의 1,2-알칸디올.Component J: 1,2-alkanediol having 5 to 10 carbon atoms.
본 발명의 피부 화장료용 조성물에 의하면, 유분을 비교적 다량으로 포함할 수 있고, 또한 투명성 및 보존 안정성이 뛰어난 피부 화장료용 조성물을 제공할 수 있다.According to the composition for skin cosmetics of the present invention, it is possible to provide a composition for skin cosmetics that can contain a relatively large amount of oil and has excellent transparency and storage stability.
본 발명의 피부 화장료용 조성물은, 인지질; 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스테롤 에테르 및/또는 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스타놀 에테르; 분기쇄를 갖는 탄소수 12∼24의 1가의 지방족 알코올; 프로필렌 글리콜, 디프로필렌 글리콜 및 1,3-부틸렌 글리콜로 이루어지는 군으로부터 선택된 1종 이상의 다가 알코올; 물; 스테롤; 유분; 옥시에틸렌의 평균 부가 몰수가 5∼30인 폴리옥시에틸렌 경화 피마자유를 적어도 포함한다. 또한, 본 명세서에 있어서, 인지질을 「성분 A」, 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스테롤 에테르 및/또는 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스타놀 에테르를 「성분 B」, 분기쇄를 갖는 탄소수 12∼24의 1가의 지방족 알코올을 「성분 C」, 프로필렌 글리콜, 디프로필렌 글리콜 및 1,3-부틸렌 글리콜로 이루어지는 군으로부터 선택된 1종 이상의 다가 알코올을 「성분 D」, 물을 「성분 E」, 스테롤을 「성분 F」, 유분을 「성분 G」, 옥시에틸렌의 평균 부가 몰수가 5∼30인 폴리옥시에틸렌 경화 피마자유를 「성분 H」라고 각각 칭하는 경우가 있다.The skin cosmetic composition of the present invention includes a phospholipid; polyoxyethylene sterol ethers having an average added mole number of oxyethylene of 15 to 50 and/or polyoxyethylene stanol ethers having an average added mole number of oxyethylene of 15 to 50; C12-C24 monohydric aliphatic alcohol which has a branched chain; at least one polyhydric alcohol selected from the group consisting of propylene glycol, dipropylene glycol and 1,3-butylene glycol; water; sterols; oil; Polyoxyethylene hydrogenated castor oil having an average added mole number of oxyethylene of 5 to 30 is included at least. In addition, in the present specification, phospholipid is "component A", polyoxyethylene sterol ether having an average added mole number of oxyethylene of 15 to 50 and/or polyoxyethylene stanol ether having an average added mole number of oxyethylene of 15 to 50 "component B", monohydric aliphatic alcohol having 12 to 24 branched carbon atoms, "component C", propylene glycol, dipropylene glycol, and 1,3-butylene glycol, and at least one polyhydric alcohol selected from the group consisting of "Component D", water as "component E", sterol as "component F", oil as "component G", polyoxyethylene hydrogenated castor oil having an average added mole number of oxyethylene of 5 to 30 as "component H", respectively. Sometimes called
본 발명의 피부 화장료용 조성물은, 추가로, 글리세린 모노2-에틸헥실 에테르를 포함하는 것이 바람직하다. 또, 본 발명의 피부 화장료용 조성물은, 추가로, 탄소수 5∼10의 1,2-알칸디올을 포함하는 것이 바람직하다. 또한, 본 명세서에 있어서, 상기 글리세린 모노2-에틸헥실 에테르를 「성분 I」라고 칭하는 경우가 있다. 또, 상기 탄소수 5∼10의 1,2-알칸디올을 「성분 J」라고 칭하는 경우가 있다.The skin cosmetic composition of the present invention preferably further contains glycerin mono2-ethylhexyl ether. Moreover, it is preferable that the composition for skin cosmetics of this invention further contains 1, 2- alkane diol of 5-10 carbon atoms. In addition, in this specification, the said glycerol mono 2-ethylhexyl ether is sometimes called "component I". Moreover, the said C5-C10 1, 2- alkane diol may be called "component J".
즉, 본 발명의 피부 화장료용 조성물은, 성분 A, 성분 B, 성분 C, 성분 D, 성분 E, 성분 F, 성분 G, 및 성분 H를 적어도 포함한다. 본 발명의 피부 화장료용 조성물은, 추가로 성분 I 및/또는 성분 J를 포함하고 있어도 된다. 또, 본 발명의 피부 화장료용 조성물은, 상기 성분 A∼J 이외의 성분을 포함하고 있어도 된다. 또, 본 발명의 피부 화장료용 조성물에 포함되는 각 성분, 예를 들면, 성분 A, 성분 B, 성분 C, 성분 D, 성분 E, 성분 F, 성분 G, 성분 H, 성분 I, 성분 J, 및 다른 성분 등의 각 성분은, 각각, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.That is, the composition for skin cosmetics of the present invention contains at least component A, component B, component C, component D, component E, component F, component G, and component H. The composition for skin cosmetics of the present invention may further contain component I and/or component J. Moreover, the composition for skin cosmetics of this invention may contain components other than the said components A-J. In addition, each component contained in the skin cosmetic composition of the present invention, for example, component A, component B, component C, component D, component E, component F, component G, component H, component I, component J, and Each component, such as another component, may respectively use only 1 type, and may use 2 or more types.
[성분 A][Component A]
성분 A는 「인지질」이다. 성분 A는 미셀의 한 형태인 바이셀 구조(인지질로 구성된 디스크상(狀)의 지질 이분자막)를 형성한다. 이 때문에, 바이셀 구조 내에 유분을 비교적 다량으로 포함할 수 있다.Component A is a "phospholipid". Component A forms a bicell structure (disc-shaped lipid bilayer film composed of phospholipids), which is a type of micelle. For this reason, a relatively large amount of oil can be contained in the bicell structure.
성분 A로는, 인산 잔기를 포함하는 복합 지질로서, 천연 인지질, 합성 인지질, 천연 유래의 인지질의 불포화 탄소쇄를 수소에 의해 포화로 한 수소 첨가 인지질 등을 들 수 있다. 상기 인지질로는, 예를 들면, 포스파티딜콜린, 포스파티딜에탄올아민, 포스파티딜세린, 포스파티딜이노시톨, 리소포스파티딜콜린, 스핑고미엘린, 난황 레시틴, 대두 레시틴 등의 천연 인지질; 디라우로일포스파티딜콜린, 디미리스토일포스파티딜콜린, 디팔미토일포스파티딜콜린, 디스테아로일포스파티딜콜린, 디올레오일포스파티딜콜린, 팔미토일·올레오일포스파티딜콜린 등의 합성 인지질; 수소 첨가 대두 레시틴, 수소 첨가 난황 레시틴, 수소 첨가 포스파티딜콜린, 수소 첨가 포스파티딜세린 등의 수소 첨가 인지질 등을 들 수 있다. 이 중, 보존 안정성이 뛰어난 관점에서, 수소 첨가 인지질이 바람직하고, 수소 첨가 대두 레시틴이 보다 바람직하다. 성분 A는, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.As component A, natural phospholipids, synthetic phospholipids, and hydrogenated phospholipids in which unsaturated carbon chains of naturally occurring phospholipids are saturated with hydrogen are exemplified as composite lipids containing a phosphoric acid residue. Examples of the phospholipid include natural phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, lysophosphatidylcholine, sphingomyelin, egg yolk lecithin, and soybean lecithin; synthetic phospholipids such as dilauroylphosphatidylcholine, dimyristoylphosphatidylcholine, dipalmitoylphosphatidylcholine, distearoylphosphatidylcholine, dioleoylphosphatidylcholine, and palmitoyl/oleoylphosphatidylcholine; and hydrogenated phospholipids such as hydrogenated soybean lecithin, hydrogenated egg yolk lecithin, hydrogenated phosphatidylcholine, and hydrogenated phosphatidylserine. Among these, from the viewpoint of excellent storage stability, hydrogenated phospholipids are preferred, and hydrogenated soybean lecithin is more preferred. Component A may use only 1 type, and may use 2 or more types.
성분 A로는, 시판품을 이용할 수 있다. 수소 첨가 대두 레시틴의 시판품으로는, 예를 들면, 상품명 「COATSOME NC-21」, 상품명 「COATSOME NC-61」(이상, 니치유 가부시키가이샤 제조), 상품명 「NIKKOL 레시놀 S-10EX」, 상품명 「NIKKOL 레시놀 S-10E」, 상품명 「NIKKOL 레시놀 S-10M」(이상, 닛코 케미컬즈 가부시키가이샤 제조), 상품명 「베이시스 LS-60HR」(닛신 오일리오 그룹 가부시키가이샤 제조) 등을 들 수 있다.As component A, a commercial item can be used. Commercially available hydrogenated soybean lecithins include, for example, brand name "COATSOME NC-21", brand name "COATSOME NC-61" (above, manufactured by Nichiyu Co., Ltd.), brand name "NIKKOL Lecinol S-10EX", brand name "NIKKOL Lesinol S-10E", trade name "NIKKOL Lesinol S-10M" (above, manufactured by Nikko Chemicals Co., Ltd.), trade name "Basis LS-60HR" (manufactured by Nissin Oilio Group Co., Ltd.), etc. can
본 발명의 피부 화장료용 조성물 중의 성분 A의 함유 비율은, 특별히 한정되지 않지만, 본 발명의 피부 화장료용 조성물의 총량 100 질량%에 대해, 0.005 질량% 이상이 바람직하고, 보다 바람직하게는 0.1 질량% 이상, 더욱 바람직하게는 0.2 질량% 이상이다. 상기 함유 비율이 0.005 질량% 이상이면, 바이셀 구조를 형성하여, 성분 F를 안정되게 분산시키고, 보존 안정성도 한층 더 뛰어나다. 상기 함유 비율의 상한은, 3.0 질량% 이하가 바람직하고, 보다 바람직하게는 2.0 질량% 이하, 더욱 바람직하게는 1.5 질량% 이하이다. 상기 함유 비율이 3.0 질량% 이하이면, 과도한 점도 상승을 억제하여, 분산성을 한층 더 향상시킬 수 있다. 상기 성분 A의 함유 비율은, 본 발명의 피부 화장료용 조성물 중의 모든 성분 A의 함유 비율의 합계이다.The content of component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.005% by mass or more, and more preferably 0.1% by mass relative to 100% by mass of the total amount of the composition for skin cosmetic of the present invention. or more, more preferably 0.2% by mass or more. When the content ratio is 0.005% by mass or more, a bicell structure is formed, component F is stably dispersed, and storage stability is further excellent. The upper limit of the content is preferably 3.0% by mass or less, more preferably 2.0% by mass or less, still more preferably 1.5% by mass or less. When the content ratio is 3.0% by mass or less, an excessive increase in viscosity can be suppressed and dispersibility can be further improved. The content rate of the component A is the sum of the content rates of all components A in the skin cosmetic composition of the present invention.
[성분 B][Component B]
성분 B는 「옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스테롤 에테르 및/또는 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스타놀 에테르」이다. 즉, 성분 B는, 상기 폴리옥시에틸렌 스테롤 에테르 및 상기 폴리옥시에틸렌 스타놀 에테르 중 어느 한쪽 또는 양쪽이다. 성분 B는 성분 A와의 친화성이 높아, 성분 A와 함께 이분자막을 형성한다. 또한, 이분자막의 곡률을 조정하고, 이것에 의해 바이셀 구조의 안정화에 기여한다고 추정된다. 성분 B로는, 산화 안정성이 뛰어난 관점에서, 폴리옥시에틸렌 스타놀 에테르가 보다 바람직하다.Component B is "polyoxyethylene sterol ether having an average added mole number of oxyethylene of 15 to 50 and/or polyoxyethylene stanol ether having an average added mole number of oxyethylene of 15 to 50". That is, component B is any one or both of the said polyoxyethylene sterol ether and the said polyoxyethylene stanol ether. Component B has high affinity with component A and forms a bimolecular film with component A. In addition, it is estimated that the curvature of the bimolecular film is adjusted, thereby contributing to the stabilization of the bicell structure. As component B, polyoxyethylene stanol ether is more preferable from the viewpoint of excellent oxidation stability.
폴리옥시에틸렌 스테롤 에테르 또는 폴리옥시에틸렌 스타놀 에테르란, 스테롤 또는 스타놀에 옥시에틸렌을 부가시킨 것이다. 스테롤 또는 스타놀에 부가시키는 옥시에틸렌의 평균 부가 몰수는 15∼50이며, 20∼30이 바람직하다.Polyoxyethylene sterol ether or polyoxyethylene stanol ether is obtained by adding oxyethylene to sterol or stanol. The average added mole number of oxyethylene added to sterol or stanol is 15 to 50, preferably 20 to 30.
성분 B로는, 예를 들면, 폴리옥시에틸렌 피토스테롤 에테르, 폴리옥시에틸렌 피토스타놀 에테르, 폴리옥시에틸렌 콜레스테롤 에테르, 폴리옥시에틸렌 콜레스타놀 에테르 등을 들 수 있다. 이 중, 식물성의 폴리옥시에틸렌 피토스테롤 에테르, 폴리옥시에틸렌 피토스타놀 에테르가 바람직하다. 성분 B는, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.Component B includes, for example, polyoxyethylene phytosterol ether, polyoxyethylene phytostanol ether, polyoxyethylene cholesterol ether, polyoxyethylene cholestanol ether and the like. Among these, vegetable polyoxyethylene phytosterol ethers and polyoxyethylene phytostanol ethers are preferred. Component B may use only 1 type, and may use 2 or more types.
성분 B로는, 시판품을 이용해도 된다. 성분 B의 시판품으로는, 예를 들면, 상품명 「NIKKOL BPS-20」, 상품명 「NIKKOL BPS-30」, 상품명 「NIKKOL BPSH-25」(이상, 닛코 케미컬즈 가부시키가이샤 제조) 등을 들 수 있다.As component B, you may use a commercial item. As a commercial item of component B, a brand name "NIKKOL BPS-20", a brand name "NIKKOL BPS-30", a brand name "NIKKOL BPSH-25" (above, manufactured by Nikko Chemicals Co., Ltd.), etc. are mentioned, for example. .
본 발명의 피부 화장료용 조성물 중의 성분 B의 함유 비율은, 특별히 한정되지 않지만, 본 발명의 피부 화장료용 조성물의 총량 100 질량%에 대해, 0.03 질량% 이상이 바람직하고, 보다 바람직하게는 1.0 질량% 이상이다. 상기 함유 비율이 0.03 질량% 이상이면, 바이셀 구조의 안정화에 충분히 기여하여, 투명성 및 보존 안정성이 한층 더 뛰어나다. 상기 함유 비율의 상한은, 15.0 질량% 이하가 바람직하고, 보다 바람직하게는 10.0 질량% 이하이다. 상기 함유 비율이 15.0 질량% 이하이면, 과도한 점도 상승을 억제하여 분산성을 한층 더 향상시킬 수 있다. 상기 성분 B의 함유 비율은, 본 발명의 피부 화장료용 조성물 중의 모든 성분 B의 함유 비율의 합계이다.The content of component B in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.03% by mass or more, and more preferably 1.0% by mass relative to 100% by mass of the total amount of the composition for skin cosmetic of the present invention. More than that. When the content ratio is 0.03% by mass or more, it sufficiently contributes to the stabilization of the bicell structure, and the transparency and storage stability are further excellent. As for the upper limit of the said content rate, 15.0 mass % or less is preferable, More preferably, it is 10.0 mass % or less. When the content ratio is 15.0% by mass or less, an excessive increase in viscosity can be suppressed and dispersibility can be further improved. The content rate of the component B is the sum of the content rates of all components B in the skin cosmetic composition of the present invention.
본 발명의 피부 화장료용 조성물 중의, 성분 A에 대한 성분 B의 질량비(B/A)는, 5.5 이상, 바람직하게는 6.0 이상, 보다 바람직하게는 7.0 이상이다. 또, 상기 질량비(B/A)는, 18.0 이하이고, 바람직하게는 15.0 이하, 보다 바람직하게는 12.0 이하이다. 상기 질량비(B/A)가, 상기 범위 내이면, 투명성 및 보존 안정성이 한층 더 뛰어나다.The mass ratio (B/A) of component B to component A in the skin cosmetic composition of the present invention is 5.5 or more, preferably 6.0 or more, more preferably 7.0 or more. Moreover, the said mass ratio (B/A) is 18.0 or less, Preferably it is 15.0 or less, More preferably, it is 12.0 or less. Transparency and storage stability are further excellent as the said mass ratio (B/A) is in the said range.
[성분 C][Component C]
성분 C는 「분기쇄를 갖는 탄소수 12∼24의 1가의 지방족 알코올」이다. 성분 C를 사용함으로써 지질 이분자막을 유연하게 하여, 안정화에 기여하는 것으로 추측된다.Component C is "a monohydric aliphatic alcohol having branched chains and having 12 to 24 carbon atoms". It is presumed that the use of component C makes the lipid bilayer membrane flexible and contributes to its stabilization.
성분 C로는, 예를 들면, 옥틸도데칸올, 데실테트라데칸올, 이소스테아릴 알코올 등을 들 수 있다. 그 중에서도, 보존 안정성 향상의 관점에서, 옥틸도데칸올, 데실테트라데칸올이 바람직하다. 성분 C는, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.As component C, octyldodecanol, decyltetradecanol, isostearyl alcohol, etc. are mentioned, for example. Especially, from a viewpoint of improving storage stability, octyldodecanol and decyl tetradecanol are preferable. Component C may use only 1 type, and may use 2 or more types.
본 발명의 피부 화장료용 조성물 중의 성분 C의 함유 비율은, 특별히 한정되지 않지만, 본 발명의 피부 화장료용 조성물의 총량 100 질량%에 대해, 0.005 질량% 이상이 바람직하고, 보다 바람직하게는 0.05 질량% 이상, 더욱 바람직하게는 0.1 질량% 이상이다. 상기 함유 비율이 0.005 질량% 이상이면, 보존 안정성이 한층 더 뛰어나다. 상기 함유 비율의 상한은, 0.5 질량% 이하가 바람직하고, 보다 바람직하게는 0.4 질량% 이하이다. 상기 함유 비율이 0.5 질량% 이하이면, 투명성을 한층 더 향상시킨다. 상기 성분 C의 함유 비율은, 본 발명의 피부 화장료용 조성물 중의 모든 성분 C의 함유 비율의 합계이다.The content of component C in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.005% by mass or more, and more preferably 0.05% by mass relative to 100% by mass of the total amount of the composition for skin cosmetic of the present invention. or more, more preferably 0.1% by mass or more. Storage stability is further excellent as the said content rate is 0.005 mass % or more. As for the upper limit of the said content rate, 0.5 mass % or less is preferable, More preferably, it is 0.4 mass % or less. Transparency is further improved as the said content rate is 0.5 mass % or less. The content rate of the component C is the sum of the content rates of all components C in the skin cosmetic composition of the present invention.
본 발명의 피부 화장료용 조성물 중의, 성분 A에 대한 성분 C의 질량비(C/A)는, 특별히 한정되지 않지만, 0.05 이상이 바람직하고, 보다 바람직하게는 0.1 이상, 더욱 바람직하게는 0.15 이상이다. 상기 질량비(C/A)가, 0.05 이상이면 보존 안정성이 한층 더 뛰어나다. 상기 질량비(C/A)의 상한은, 1.0 이하가 바람직하고, 보다 바람직하게는 0.7 이하, 더욱 바람직하게는 0.5 이하이다. 상기 질량비(C/A)가, 1.0 이하이면, 투명성이 한층 더 뛰어나다.The mass ratio (C/A) of component C to component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.05 or more, more preferably 0.1 or more, still more preferably 0.15 or more. The storage stability is further excellent as the said mass ratio (C/A) is 0.05 or more. The upper limit of the mass ratio (C/A) is preferably 1.0 or less, more preferably 0.7 or less, still more preferably 0.5 or less. Transparency is further excellent as the said mass ratio (C/A) is 1.0 or less.
[성분 D][Component D]
성분 D는 「프로필렌 글리콜, 디프로필렌 글리콜 및 1,3-부틸렌 글리콜로 이루어지는 군으로부터 선택된 1종 이상의 다가 알코올」이다. 성분 D는 피부 화장료용 조성물의 제조 시에 있어서의 다른 성분의 용매로서 기능한다. 특히, 성분 D의 특정 3성분을 이용함으로써, 다른 성분을 분산한 경우의 분산액의 점도 상승이 억제되어, 분산성이 향상된다. 성분 D는, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.Component D is “one or more polyhydric alcohols selected from the group consisting of propylene glycol, dipropylene glycol and 1,3-butylene glycol”. Component D functions as a solvent for other components in the preparation of a skin cosmetic composition. In particular, by using the specific three components of component D, the increase in viscosity of the dispersion liquid when other components are dispersed is suppressed, and the dispersibility is improved. Component D may use only 1 type, and may use 2 or more types.
본 발명의 피부 화장료용 조성물 중의 성분 D의 함유 비율은, 특별히 한정되지 않지만, 본 발명의 피부 화장료용 조성물의 총량 100 질량%에 대해, 0.25 질량% 이상이 바람직하고, 보다 바람직하게는 3.0 질량% 이상, 더욱 바람직하게는 5.0 질량% 이상이다. 상기 함유 비율의 상한은, 30.0 질량% 이하가 바람직하고, 보다 바람직하게는 25.0 질량% 이하, 더욱 바람직하게는 15.0 질량% 이하이다. 상기 함유 비율이 상기 범위 내이면, 투명성 및 보존 안정성이 한층 더 뛰어나다. 상기 성분 D의 함유 비율은, 본 발명의 피부 화장료용 조성물 중의 모든 성분 D의 함유 비율의 합계이다.The content of component D in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.25% by mass or more, and more preferably 3.0% by mass relative to 100% by mass of the total amount of the composition for skin cosmetic of the present invention. or more, more preferably 5.0% by mass or more. The upper limit of the content is preferably 30.0% by mass or less, more preferably 25.0% by mass or less, still more preferably 15.0% by mass or less. Transparency and storage stability are further excellent as the said content rate is in the said range. The content rate of the component D is the sum of the content rates of all components D in the skin cosmetic composition of the present invention.
본 발명의 피부 화장료용 조성물 중의, 성분 A에 대한 성분 D의 질량비(D/A)는, 특별히 한정되지 않지만, 8.0 이상이 바람직하고, 보다 바람직하게는 10.0 이상이다. 상기 질량비(D/A)의 상한은, 60.0 이하가 바람직하고, 보다 바람직하게는 30.0 이하, 더욱 바람직하게는 20.0 이하이다. 상기 질량비(D/A)가 상기 범위 내이면, 피부 화장료용 조성물의 백탁 방지가 한층 더 뛰어나다.The mass ratio (D/A) of component D to component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 8.0 or more, and more preferably 10.0 or more. The upper limit of the mass ratio (D/A) is preferably 60.0 or less, more preferably 30.0 or less, still more preferably 20.0 or less. When the mass ratio (D/A) is within the above range, the cloudiness prevention of the composition for skin cosmetics is further excellent.
[성분 E][Component E]
성분 E는 「물」이다. 물을 사용함으로써, 본 발명의 피부 화장료용 조성물에 촉촉함과 산뜻한 감을 부여할 수 있고, 더 나아가서는 본 발명의 피부 화장료용 조성물을 수계 로션 등의 피부 화장료에 적용할 수 있다.Component E is "water". By using water, it is possible to impart moisture and a fresh feeling to the composition for skin cosmetics of the present invention, and furthermore, the composition for skin cosmetics of the present invention can be applied to skin cosmetics such as water-based lotions.
본 발명의 피부 화장료용 조성물 중의 성분 E의 함유 비율은, 특별히 한정되지 않지만, 본 발명의 피부 화장료용 조성물의 총량 100 질량%에 대해, 55.0 질량% 이상이 바람직하고, 보다 바람직하게는 60.0 질량% 이상, 더욱 바람직하게는 65.0 질량% 이상이다. 상기 함유 비율은, 95.0 질량% 이하가 바람직하고, 보다 바람직하게는 90.0 질량% 이하, 더욱 바람직하게는 85.0 질량% 이하이다. 상기 배합 비율이, 상기 범위 내이면, 수계 로션에 적용할 때의 간편성 및 산뜻한 사용감이 얻어지기 때문에 바람직하다.The content of component E in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 55.0% by mass or more, and more preferably 60.0% by mass relative to 100% by mass of the total amount of the composition for skin cosmetic of the present invention. or more, more preferably 65.0 mass% or more. As for the said content rate, 95.0 mass % or less is preferable, More preferably, it is 90.0 mass % or less, More preferably, it is 85.0 mass % or less. When the above blending ratio is within the above range, it is preferable because convenience and refreshing feeling when applied to a water-based lotion are obtained.
[성분 F][Component F]
성분 F는 「스테롤」이다. 성분 F는, 이분자막의 곡률을 조정하고, 이것에 의해 바이셀 구조의 안정화에 기여한다고 추정된다. 또, 피부의 배리어 기능 향상 등을 위한 유효 성분으로서도 배합된다.Component F is a "sterol". Component F is presumed to contribute to the stabilization of the bicell structure by adjusting the curvature of the bimolecular film. In addition, it is blended as an active ingredient for improving skin barrier function and the like.
성분 F로는, 예를 들면, 동물 스테롤, 식물 스테롤(피토스테롤) 등을 들 수 있다. 동물 스테롤로는, 예를 들면, 콜레스테롤, 콜레스타놀, 7-디히드로콜레스테롤 등을 들 수 있다. 또, 식물 스테롤로는, 예를 들면, 시토스테롤, 스티그마스테롤, 푸코스테롤, 스피나스테롤, 브라시카스테롤 등을 들 수 있다. 성분 F는, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.Component F includes, for example, animal sterols and plant sterols (phytosterols). Examples of animal sterols include cholesterol, cholestanol, and 7-dihydrocholesterol. Moreover, as a plant sterol, sitosterol, stigmasterol, fucosterol, spinasterol, brassicasterol etc. are mentioned, for example. Component F may use only 1 type, and may use 2 or more types.
성분 F로는, 시판품을 이용할 수 있다. 성분 F의 시판품으로는, 예를 들면, 상품명 「콜레스테롤 JSQI」, 상품명 「니혼약쿄쿠호 콜레스테롤」(이상, 닛폰 세이카 가부시키가이샤 제조), 상품명 「피토스테롤」(에자이 푸드·케미컬 가부시키가이샤 제조), 상품명 「피토스테롤-SKP」(다마 세이카가쿠 가부시키가이샤 제조) 등을 들 수 있다.As component F, a commercial item can be used. Commercially available products of component F include, for example, brand name "Cholesterol JSQI", brand name "Nippon Yak Kyokuho Cholesterol" (above, manufactured by Nippon Seika Co., Ltd.), brand name "Phytosterol" (manufactured by Eisai Food Chemical Co., Ltd.) , trade name "Phytosterol-SKP" (manufactured by Tama Seikagaku Co., Ltd.), and the like.
본 발명의 피부 화장료용 조성물 중의 성분 F의 함유 비율은, 특별히 한정되지 않지만, 본 발명의 피부 화장료용 조성물의 총량 100 질량%에 대해, 0.01 질량% 이상이 바람직하고, 보다 바람직하게는 0.1 질량% 이상, 더욱 바람직하게는 0.2 질량% 이상이다. 상기 함유 비율이, 0.01 질량% 이상이면, 피부에 배리어 기능 등을 부여할 수 있다. 상기 함유 비율의 상한은, 2.0 질량% 이하가 바람직하고, 보다 바람직하게는 1.0 질량% 이하, 더욱 바람직하게는 0.6 질량% 이하이다. 상기 질량 비율이, 2.0 질량% 이하이면, 보존 안정성의 향상이 한층 더 뛰어나다. 상기 성분 F의 함유 비율은, 본 발명의 피부 화장료용 조성물 중의 모든 성분 F의 함유 비율의 합계이다.The content of component F in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.01% by mass or more, more preferably 0.1% by mass, relative to 100% by mass of the total amount of the composition for skin cosmetic of the present invention. or more, more preferably 0.2% by mass or more. If the said content rate is 0.01 mass % or more, a barrier function etc. can be provided to skin. The upper limit of the content ratio is preferably 2.0% by mass or less, more preferably 1.0% by mass or less, still more preferably 0.6% by mass or less. When the mass ratio is 2.0% by mass or less, the improvement in storage stability is further excellent. The content rate of the component F is the sum of the content rates of all components F in the skin cosmetic composition of the present invention.
[성분 G][Component G]
성분 G는 「유분」이다. 성분 G로는, 예를 들면, 식물유, 에스테르유, 실리콘유, 탄화수소유, 납(蠟), 고급 지방산, 성분 C 이외의 고급 알코올 등을 들 수 있다. 성분 G는 본 발명의 피부 화장료용 조성물에 있어서, 피부의 수분의 증산을 막고, 각질을 유연하게 하는 등의 에몰리언트 성분으로서 이용된다. 또한 성분 G에는, 성분 F에 해당하는 것은 포함되지 않는 것으로 한다. 성분 G는, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.Component G is "oil". As component G, vegetable oil, ester oil, silicone oil, hydrocarbon oil, lead, higher fatty acids, higher alcohols other than component C, etc. are mentioned, for example. In the skin cosmetic composition of the present invention, component G is used as an emollient component for preventing evaporation of skin moisture and softening keratin. In addition, component G shall not contain what corresponds to component F. Component G may use only 1 type, and may use 2 or more types.
상기 식물유로는, 예를 들면, 마카데미아넛유, 유칼리유, 야자유, 아보카도유, 홍화유, 올리브유, 팜유, 팜핵유, 쿠쿠이넛유, 시어기름(시어 버터), 카카오 버터, 아몬드유, 해바라기유, 로즈힙유, 올리브 스쿠알란, 키위 프루트 시드유, 살구씨유, 참기름, 대두유, 호호바유, 피마자유, 헤이즐넛유, 메도우폼유, 박하유, 아르간 오일, 캐럿 오일, 라벤더유, 슈가 스쿠알란, 다마스크 장미꽃 납(Rosa Damascena Flower Wax), 센티폴리아 장미꽃 납(Rosa Centifolia Flower Wax), 자스민꽃 왁스, 동백유, 이들의 수소 첨가물(예를 들면, 수소 첨가 피마자유, 수소 첨가 호호바유, 수소 첨가 팜유, 수소 첨가 아보카도유, 수소 첨가 대두유 등) 등을 들 수 있다.Examples of the vegetable oil include macadamia nut oil, eucalyptus oil, palm oil, avocado oil, safflower oil, olive oil, palm oil, palm kernel oil, kukui nut oil, shea oil (shea butter), cacao butter, almond oil, sunflower oil, Rosehip Oil, Olive Squalane, Kiwifruit Seed Oil, Apricot Seed Oil, Sesame Oil, Soybean Oil, Jojoba Oil, Castor Oil, Hazelnut Oil, Meadowfoam Oil, Peppermint Oil, Argan Oil, Carrot Oil, Lavender Oil, Sugar Squalane, Damask Rose Lead (Rosa Damascena Flower Wax), Rosa Centifolia Flower Wax, jasmine flower wax, camellia oil, hydrogenated products thereof (e.g. hydrogenated castor oil, hydrogenated jojoba oil, hydrogenated palm oil, hydrogenated oil) avocado oil, hydrogenated soybean oil, etc.); and the like.
상기 에스테르유로는, 예를 들면, 올레인산 에틸, 미리스틴산 이소프로필, 팔미틴산 이소프로필, 미리스틴산 미리스틸, 팔미틴산 세틸, 팔미틴산 2-에틸헥실, 미리스틴산 옥틸도데실, 이소스테아린산 이소프로필, 이소스테아린산 프로필렌 글리콜, 2-에틸헥산산 세틸, 트리2-에틸헥산산 글리세릴, 트리(카프릴산/카프린산) 글리세릴, 이소노난산 이소노닐, 아디핀산 디이소프로필, 테트라옥탄산 펜타에리스리틸, 테트라이소스테아린산 펜타에리트리트, 사과산 디이소스테아릴, 트리에틸헥산산 에리스리틸, 히드록시스테아린산 2-에틸헥실, 헥사(히드록시스테아린산/스테아린산/로진산) 디펜타에리스리틸, 테트라(히드록시스테아린산/이소스테아린산) 디펜타에리스리틸, 헥사히드록시스테아린산 디펜타에리스리틸, (에틸헥산산/스테아린산/아디핀산) 글리세릴, 트리(카프릴산/카프린산/미리스틴산/스테아린산) 글리세릴, 헥사(베헨산/안식향산/에틸헥산산) 디펜타에리스리틸, 안식향산 알킬(C12-15) 등을 들 수 있다.Examples of the ester oil include ethyl oleate, isopropyl myristate, isopropyl palmitate, myristyl myristate, cetyl palmitate, 2-ethylhexyl palmitate, octyldodecyl myristate, isopropyl isostearate, iso Propylene glycol stearate, cetyl 2-ethylhexanoate, glyceryl tri2-ethylhexanoate, tri(caprylic/capric acid) glyceryl, isononanoate isononyl, diisopropyl adipate, pentaerys tetraoctanoate lytyl, pentaerythrite tetraisostearate, diisostearyl malate, erythrityl triethylhexanoate, 2-ethylhexyl hydroxystearate, hexa(hydroxystearic acid/stearic acid/rosinic acid) dipentaerythrityl, tetra(hydroxy Stearic acid/isostearic acid) dipentaerythrityl, hexahydroxystearic acid dipentaerythrityl, (ethylhexanoic acid/stearic acid/adipic acid) glyceryl, tri(caprylic/capric acid/myristic acid/stearic acid) glyceryl , hexa(behenic acid/benzoic acid/ethylhexanoic acid) dipentaerythrityl, alkyl benzoate (C12-15), and the like.
상기 실리콘유로는, 특별히 한정되지 않지만, 예를 들면, 메틸폴리실록산, 고중합 메틸폴리실록산 등의 디메틸 실리콘유; 메틸페닐폴리실록산 등의 메틸페닐 실리콘유; 메틸시클로폴리실록산, 옥타메틸시클로테트라실록산, 데카메틸시클로펜타실록산, 도데카메틸시클로헥사실록산 등의 환상(環狀) 실리콘유; 아미노프로필메틸실록산·디메틸실록산 공중합체, 아미노에틸아미노프로필실록산·디메틸실록산 공중합체, 아미노에틸아미노프로필메틸실록산·디메틸실록산 공중합체 등의 아미노 변성 실리콘, 카르복시 변성 실리콘, 지방산 변성 실리콘, 알코올 변성 실리콘, 지방족 알코올 변성 실리콘, 에폭시 변성 실리콘, 불소 변성 실리콘, 알킬 변성 실리콘 등의 변성 실리콘; 메틸하이드로젠폴리실록산, 디메티콘올 등을 들 수 있다.Examples of the silicone oil include, but are not particularly limited to, dimethyl silicone oils such as methylpolysiloxane and highly polymerized methylpolysiloxane; methylphenyl silicone oils such as methylphenylpolysiloxane; cyclic silicone oils such as methylcyclopolysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexasiloxane; amino-modified silicones such as aminopropylmethylsiloxane/dimethylsiloxane copolymer, aminoethylaminopropylsiloxane/dimethylsiloxane copolymer, aminoethylaminopropylmethylsiloxane/dimethylsiloxane copolymer, carboxy-modified silicone, fatty acid-modified silicone, alcohol-modified silicone, modified silicones such as aliphatic alcohol-modified silicone, epoxy-modified silicone, fluorine-modified silicone, and alkyl-modified silicone; Methyl hydrogen polysiloxane, dimethiconol, etc. are mentioned.
상기 탄화수소유로는, 예를 들면, α-올레핀 올리고머, 바셀린, 이소파라핀, 경질 이소파라핀, 경질 유동 이소파라핀, 스쿠알란, 합성 스쿠알란, 식물성 스쿠알란, 유동 이소파라핀, 유동 파라핀 등, 수소 첨가 폴리이소부텐, 수소 첨가(테트라데세닐/메틸펜타데센), 이소도데칸 등을 들 수 있다.Examples of the hydrocarbon oil include α-olefin oligomer, vaseline, isoparaffin, light isoparaffin, light liquid isoparaffin, squalane, synthetic squalane, vegetable squalane, liquid isoparaffin, liquid paraffin, etc., hydrogenated polyisobutene, Hydrogenated (tetradecenyl/methylpentadecene), isododecane, etc. are mentioned.
상기 납(蠟)으로는, 예를 들면, 카르나우바납, 칸델릴라납, 밀랍, 미강(米糠)납, 셸락납, 경랍(鯨蠟), 라놀린, 해바라기 종자납 등을 들 수 있다.Examples of the wax include carnauba wax, candelilla wax, beeswax, rice bran wax, shellac wax, spermaceti wax, lanolin, and sunflower seed wax.
상기 고급 지방산으로는, 예를 들면, 라우린산, 미리스틴산, 팔미틴산, 스테아린산, 이소스테아린산, 올레인산 등을 들 수 있다.Examples of the higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, isostearic acid, and oleic acid.
상기 성분 C 이외의 고급 알코올로는, 예를 들면, 세틸 알코올, 스테아릴 알코올, 미리스틸 알코올, 올레일 알코올 등을 들 수 있다.Examples of higher alcohols other than the component C include cetyl alcohol, stearyl alcohol, myristyl alcohol, and oleyl alcohol.
그 중에서도, 성분 G로는, 고극성(高極性)의 유분을 포함하는 것이 바람직하다. 또, 상기 고극성의 유분은, 스테롤 골격을 갖는 것이 보다 바람직하다. 성분 G로서 고극성의 유분을 포함하면, 에몰리언트 효과가 더욱더 향상한다. 고극성의 유분은, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.Especially, as component G, it is preferable to contain a highly polar oil component. Moreover, it is more preferable that the highly polar oil component has a sterol skeleton. When highly polar oil is included as component G, the emollient effect is further improved. As for the highly polar oil, only one type may be used, or two or more types may be used.
상기 고극성의 유분으로는, 식물 유래, 동물 유래, 및 광물 유래 중의 어느 것도 사용 가능하다. 극성 유지로는, 예를 들면, 수소 첨가 팜유, 수소 첨가 호호바유, 시어기름, (아디핀산·2-에틸헥산산·스테아린산) 글리세릴올리고에스테르, 마카데미아넛 지방산 피토스테릴, 트리카프릴산 글리세릴, 트리카프린산 글리세릴, 트리미리스틴산 글리세릴, 트리스테아린산 글리세릴, 올레인산 피토스테릴, 히드록시스테아린산 디펜타에리스리틸, 스테아린산 디펜타에리스리틸, 로진산 디펜타에리스리틸, 헥사히드록시스테아린산 디펜타에리스리틸 등을 들 수 있다. 본 발명의 피부 화장료용 조성물의 에몰리언트 효과를 더욱더 높이는 관점에서는, 올레인산 피토스테릴이 바람직하다.Any of plant-derived, animal-derived, and mineral-derived oils can be used as the highly polar oil. As polar oils, for example, hydrogenated palm oil, hydrogenated jojoba oil, shea oil, (adipic acid, 2-ethylhexanoic acid, stearic acid) glyceryl oligoesters, macadamia nut fatty acid phytosteryl, tricapryl Glyceryl acid, glyceryl tricaprate, glyceryl trimyristate, glyceryl tristearate, phytosteryl oleate, dipentaerythrityl hydroxystearate, dipentaerythrityl stearate, dipentaerythrityl rosinate, hexa Dipentaerythrityl hydroxystearate etc. are mentioned. From the viewpoint of further enhancing the emollient effect of the skin cosmetic composition of the present invention, phytosteryl oleate is preferred.
본 발명의 피부 화장료용 조성물 중의 성분 G의 함유 비율은, 특별히 한정되지 않지만, 본 발명의 피부 화장료용 조성물의 총량 100 질량%에 대해, 0.01 질량% 이상이 바람직하고, 보다 바람직하게는 0.05 질량% 이상이다. 상기 함유 비율이 0.01 질량% 이상이면, 보습이나 각질 유연 등의 에몰리언트 효과를 한층 더 발휘한다. 상기 함유 비율은, 0.3 질량% 이하가 바람직하고, 보다 바람직하게는 0.2 질량% 이하이다. 상기 함유 비율이 0.3 질량% 이하이면, 보존 안정성이 더욱더 뛰어나다. 상기 성분 G의 함유 비율은, 본 발명의 피부 화장료용 조성물 중의 모든 성분 G의 함유 비율의 합계이다.The content of component G in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.01% by mass or more, more preferably 0.05% by mass relative to 100% by mass of the total amount of the composition for skin cosmetic of the present invention. More than that. When the content ratio is 0.01% by mass or more, emollient effects such as moisturizing and keratin softening are further exhibited. As for the said content rate, 0.3 mass % or less is preferable, More preferably, it is 0.2 mass % or less. When the content ratio is 0.3% by mass or less, the storage stability is further improved. The content rate of the component G is the sum of the content rates of all components G in the skin cosmetic composition of the present invention.
본 발명의 피부 화장료용 조성물 중의, 성분 A에 대한 성분 G의 질량비(G/A)는, 특별히 한정되지 않지만, 0.01 이상이 바람직하고, 보다 바람직하게는 0.02이며, 더욱 바람직하게는 0.05 이상이다. 상기 질량비(G/A)는, 1.0 이하가 바람직하고, 보다 바람직하게는 0.8 이하, 더욱 바람직하게는 0.5 이하이다. 상기 질량비(G/A)가, 상기 범위 내이면 보존 안정성이 한층 더 뛰어나다.The mass ratio (G/A) of component G to component A in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.01 or more, more preferably 0.02, still more preferably 0.05 or more. The mass ratio (G/A) is preferably 1.0 or less, more preferably 0.8 or less, still more preferably 0.5 or less. The storage stability is further excellent when the said mass ratio (G/A) is in the said range.
[성분 H][Component H]
성분 H는, 「옥시에틸렌의 평균 부가 몰수가 5∼30인 폴리옥시에틸렌 경화 피마자유」이다. 성분 H는, 본 발명의 피부 화장료용 조성물에 있어서, 이분자막의 곡률을 조정하고, 이것에 의해 바이셀 구조의 안정화에 기여한다고 추정된다. 특히, 성분 G를 안정적으로 막 중에 가두어, 보존 안정성을 높이는 효과를 발휘한다. 성분 H는, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.Component H is “polyoxyethylene hydrogenated castor oil having an average added mole number of oxyethylene of 5 to 30”. Component H is presumed to contribute to the stabilization of the bicell structure by adjusting the curvature of the bimolecular film in the skin cosmetic composition of the present invention. In particular, the effect of stably confining component G in the film and enhancing storage stability is exhibited. Component H may use only 1 type, and may use 2 or more types.
성분 H의 옥시에틸렌의 평균 부가 몰수는 5∼30이다. 평균 부가 몰수는 바람직하게는 10 이상, 보다 바람직하게는 15 이상, 바람직하게는 25 이하이다. 성분 H의 옥시에틸렌의 평균 부가 몰수가 상기의 바람직한 범위 내이면, 유분을 안정적으로 바이셀 중에 가두어, 보존 안정성을 높이는 효과를 한층 더 발휘한다. 그중에서도, 성분 H로는, 옥시에틸렌의 평균 부가 몰수가 20인 폴리옥시에틸렌 경화 피마자유가 가장 바람직하다.The average added mole number of oxyethylene of component H is 5-30. The average added mole number is preferably 10 or more, more preferably 15 or more, and preferably 25 or less. When the average added mole number of oxyethylene of component H is within the above preferred range, the effect of stably trapping oil in the bicell and enhancing storage stability is further exhibited. Among them, as component H, polyoxyethylene hydrogenated castor oil having an average number of added moles of oxyethylene of 20 is most preferred.
성분 H의 HLB(Hydrophile-Lipophile Balance)치(値)는, 특별히 한정되지 않지만, 예를 들면 6.0∼11.0, 바람직하게는 6.5∼10.5이다. HLB치가 상기 범위인 성분 H를 사용하면, 보존 안정성에 기여한다. 성분 H의 HLB치가 친유성을 나타낼수록, 보다 양호한 보존 안정성을 발휘한다. 또한, 상기 HLB치는, 그리핀(Griffin)법에 의해 산출할 수 있다.The HLB (Hydrophile-Lipophile Balance) value of component H is not particularly limited, but is, for example, 6.0 to 11.0, preferably 6.5 to 10.5. When component H whose HLB value is within the above range is used, it contributes to storage stability. The more lipophilic the HLB value of component H is, the better storage stability is exhibited. In addition, the said HLB value is computable by the Griffin method.
본 발명의 피부 화장료용 조성물 중의 성분 H의 함유 비율은, 특별히 한정되지 않지만, 본 발명의 피부 화장료용 조성물의 총량 100 질량%에 대해, 0.05 질량% 이상이 바람직하고, 보다 바람직하게는 0.5 질량% 이상이다. 상기 함유 비율은, 5.0 질량% 이하가 바람직하고, 보다 바람직하게는 3.0 질량% 이하, 더욱 바람직하게는 2.0 질량% 이하이다. 상기 함유 비율이, 상기 범위 내이면 성분 G를 안정적으로 지질 이분자막 중에 가두는 효과가 한층 더 뛰어나다. 상기 성분 H의 함유 비율은, 본 발명의 피부 화장료용 조성물 중의 모든 성분 H의 함유 비율의 합계이다.The content of component H in the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.05% by mass or more, and more preferably 0.5% by mass relative to 100% by mass of the total amount of the composition for skin cosmetic of the present invention. More than that. The content ratio is preferably 5.0% by mass or less, more preferably 3.0% by mass or less, still more preferably 2.0% by mass or less. When the content ratio is within the above range, the effect of stably confining component G in the lipid bilayer film is further excellent. The content rate of the component H is the sum of the content rates of all components H in the skin cosmetic composition of the present invention.
[성분 I][Component I]
성분 I는, 「글리세린 모노2-에틸헥실 에테르」(「옥톡시글리세린」이라고도 칭해진다.)이다. 성분 I를 함유하는 경우, 바이셀 구조의 지질 이분자막 내에 들어가기 때문에, 막 형상에 유연성이 부여된다고 추정된다. 이 때문에, 본 발명의 피부 화장료용 조성물은, 투명성과 보존 안정성이 더욱더 향상한다.Component I is "glycerol mono 2-ethylhexyl ether" (also referred to as "octoxyglycerin"). In the case of containing component I, it is presumed that flexibility is imparted to the membrane shape because it enters the lipid bilayer membrane of the bicell structure. For this reason, the skin cosmetic composition of the present invention further improves transparency and storage stability.
본 발명의 피부 화장료용 조성물이 성분 I를 함유하는 경우, 본 발명의 피부 화장료용 조성물 중의 성분 I의 함유 비율은, 특별히 한정되지 않지만, 본 발명의 피부 화장료용 조성물의 총량 100 질량%에 대해, 0.01 질량% 이상이 바람직하고, 보다 바람직하게는 0.05 질량% 이상, 더욱 바람직하게는 0.1 질량% 이상이다. 상기 함유 비율이, 0.01 질량% 이상이면, 투명성과 보존 안정성이 한층 더 뛰어나다. 상기 함유 비율의 상한은, 2.0 질량% 이하가 바람직하고, 보다 바람직하게는 1.5 질량% 이하, 더욱 바람직하게는 1.0 질량% 이하이다. 상기 함유 비율이 2.0 질량% 이하이면, 보다 저자극성의 제(劑)로 할 수 있다.When the composition for skin cosmetics of the present invention contains component I, the content ratio of component I in the composition for skin cosmetics of the present invention is not particularly limited, but with respect to 100% by mass of the total amount of the composition for skin cosmetics of the present invention, 0.01 mass % or more is preferable, More preferably, it is 0.05 mass % or more, More preferably, it is 0.1 mass % or more. Transparency and storage stability are further excellent as the said content rate is 0.01 mass % or more. The upper limit of the content is preferably 2.0% by mass or less, more preferably 1.5% by mass or less, still more preferably 1.0% by mass or less. When the content ratio is 2.0% by mass or less, a more mild agent can be obtained.
[성분 J][Component J]
성분 J는, 「탄소수 5∼10의 1,2-알칸디올」이다. 성분 J를 함유하는 경우, 바이셀 구조의 지질 이분자막 내에 들어가기 때문에, 막 형상에 유연성이 부여된다고 추정된다. 이 때문에, 본 발명의 피부 화장료용 조성물은, 투명성과 보존 안정성이 더욱더 향상한다.Component J is "a 1,2-alkanediol having 5 to 10 carbon atoms". In the case of containing component J, it is presumed that flexibility is imparted to the membrane shape because it enters the lipid bilayer membrane of the bicell structure. For this reason, the skin cosmetic composition of the present invention further improves transparency and storage stability.
성분 J로는, 예를 들면, 1,2-펜탄디올, 1,2-헥산디올, 1,2-옥탄디올, 1,2-데칸디올 등을 들 수 있다. 성분 J는, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.As component J, 1, 2- pentanediol, 1, 2- hexanediol, 1, 2- octanediol, 1, 2- decanediol etc. are mentioned, for example. Component J may use only 1 type, and may use 2 or more types.
본 발명의 피부 화장료용 조성물이 성분 J를 함유하는 경우, 본 발명의 피부 화장료용 조성물 중의 성분 J의 함유 비율은, 특별히 한정되지 않지만, 본 발명의 피부 화장료용 조성물의 총량 100 질량%에 대해, 0.01 질량% 이상이 바람직하고, 보다 바람직하게는 0.1 질량% 이상, 더욱 바람직하게는 0.2 질량% 이상이다. 상기 함유 비율이, 0.01 질량% 이상이면, 투명성과 보존 안정성이 한층 더 뛰어나다. 상기 함유 비율의 상한은, 2.0 질량% 이하가 바람직하고, 보다 바람직하게는 1.0 질량% 이하, 더욱 바람직하게는 0.7 질량% 이하이다. 상기 함유 비율이 2.0 질량% 이하이면, 보다 저자극성의 제로 할 수 있다. 상기 성분 J의 함유 비율은, 본 발명의 피부 화장료용 조성물 중의 모든 성분 J의 함유 비율의 합계이다.When the skin cosmetic composition of the present invention contains component J, the content ratio of component J in the skin cosmetic composition of the present invention is not particularly limited, but relative to the total amount of 100% by mass of the skin cosmetic composition of the present invention, 0.01 mass % or more is preferable, More preferably, it is 0.1 mass % or more, More preferably, it is 0.2 mass % or more. Transparency and storage stability are further excellent as the said content rate is 0.01 mass % or more. The upper limit of the content is preferably 2.0% by mass or less, more preferably 1.0% by mass or less, still more preferably 0.7% by mass or less. When the content ratio is 2.0% by mass or less, a more mild agent can be obtained. The content rate of the component J is the sum of the content rates of all components J in the skin cosmetic composition of the present invention.
[기타 성분][Other Ingredients]
본 발명의 피부 화장료용 조성물에는, 상기 성분 A∼J 이외의 기타 성분이 추가로 함유되어 있어도 된다. 상기 기타 성분으로는, 특별히 한정되지 않지만, 예를 들면, 성분 H 이외의 계면활성제(양이온 계면활성제, 음이온 계면활성제, 비이온 계면활성제, 양성 계면활성제 등), 저급 알코올, 성분 C 이외의 고급 알코올, 성분 D 이외의 다가 알코올, 자외선 흡수제, 분체(粉體), 산화 방지제, 방부제, 향료, 착색제, 킬레이트제, 청량제, 증점제(增粘劑), 비타민류, 중화제, 아미노산, pH 조정제, 미백제, 항염증제, 소취제, 동식물 추출물, 금속 이온 봉쇄제 등의 첨가제 등을 들 수 있다. 상기 기타 성분은, 1종만을 이용해도 되고, 2종 이상을 이용해도 된다.The skin cosmetic composition of the present invention may further contain other components other than the above components A to J. Examples of the other components include, but are not particularly limited to, surfactants other than component H (cationic surfactants, anionic surfactants, nonionic surfactants, amphoteric surfactants, etc.), lower alcohols, and higher alcohols other than component C. , polyhydric alcohols other than component D, ultraviolet absorbers, powders, antioxidants, preservatives, fragrances, coloring agents, chelating agents, cooling agents, thickeners, vitamins, neutralizers, amino acids, pH adjusters, whitening agents, and additives such as anti-inflammatory agents, deodorants, animal and plant extracts, and metal ion sequestering agents. As for the said other component, only 1 type may be used, and 2 or more types may be used.
본 발명의 피부 화장료용 조성물의 외관은, 심미성(審美性)의 관점에서, 투명한 상태의 것이 바람직하다. 또, 본 발명의 피부 화장료용 조성물의 투명성이 높은 것은, 배합된 유분의 응집이나 크리밍이 발생하고 있지 않은 것을 의미하고, 매우 안정된 상태인 것을 나타내고 있다. 이 때문에 본 발명의 피부 화장료용 조성물의 투명성은 보존 안정성의 지표가 되기도 한다.The external appearance of the skin cosmetic composition of the present invention is preferably in a transparent state from the viewpoint of aesthetics. In addition, the high transparency of the skin cosmetic composition of the present invention means that no aggregation or creaming of the blended oil components has occurred, indicating that it is in a very stable state. For this reason, the transparency of the skin cosmetic composition of the present invention is also an index of storage stability.
본 발명의 피부 화장료용 조성물 중에 있어서는, 성분 A(인지질)는 미셀의 한 형태인 바이셀 구조를 형성한다. 바이셀 구조란, 인지질로 구성된 디스크상(狀)의 지질 이분자막이다. 본 발명의 피부 화장료용 조성물에 있어서의 바이셀 구조는, 미셀과 리포솜의 중간인, 20∼50nm 정도의 입경을 갖는다. 상기 바이셀 구조는, 지질 이분자막 내에 유분을 배합할 수 있기 때문에, 미셀보다도, 보다 많은 유분을 배합할 수 있다. 게다가, 리포솜 정도의 입경을 갖지 않기 때문에, 보존 안정성도 뛰어나다. 또, 상기 바이셀 구조이면, 투명성도 손상되는 일이 없다.In the skin cosmetic composition of the present invention, component A (phospholipid) forms a bicell structure, which is a type of micelle. The bicell structure is a disc-shaped lipid bilayer film composed of phospholipids. The bicell structure in the skin cosmetic composition of the present invention has a particle diameter of about 20 to 50 nm, which is intermediate between micelles and liposomes. Since the bicell structure can incorporate oil into the lipid bilayer membrane, more oil can be incorporated than micelles. In addition, since it does not have a particle size comparable to that of liposomes, it is also excellent in storage stability. Moreover, if it is the said bicell structure, transparency is also not impaired.
또, 상기의 이유에서, 본 발명의 피부 화장료용 조성물은, 인지질로 형성된 리포솜을 함유하고 있지 않은 피부 화장료용 조성물인 것이 바람직하다.For the above reasons, the composition for skin cosmetics of the present invention is preferably a composition for skin cosmetics that does not contain liposomes formed of phospholipids.
본 발명의 피부 화장료용 조성물의 pH는, 특별히 한정되지 않지만, 예를 들면, 25℃에 있어서 5.0∼8.0인 것이 바람직하다.The pH of the skin cosmetic composition of the present invention is not particularly limited, but is preferably, for example, 5.0 to 8.0 at 25°C.
본 발명의 피부 화장료용 조성물의 점도는, 특별히 한정되지 않지만, 예를 들면, 25℃에서의 점도가 0.5∼1000mPa·s인 것이 바람직하고, 0.5∼500mPa·s인 것이 보다 바람직하다. 점도 측정은 B형 점도계를 이용하고, 점도에 맞는 로터를 선택하여, 회전수 60r/min으로 실시한다.The viscosity of the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.5 to 1000 mPa·s, and more preferably 0.5 to 500 mPa·s, for example, at 25°C. Viscosity measurement is performed at a rotational speed of 60 r/min using a B-type viscometer and selecting a rotor suitable for the viscosity.
본 발명의 피부 화장료용 조성물의 바이셀 구조의 평균 입자 지름은, 특별히 한정되지 않지만, 20nm 이상이 바람직하고, 보다 바람직하게는 30nm 이상, 더욱 바람직하게는 40nm 이상이다. 상기 평균 입자 지름의 하한이, 20nm 이상인 것에 의해, 바이셀 구조 내에 성분 G를 도입할 스페이스를 확보할 수 있다. 상기 평균 입자 지름의 상한은, 바람직하게는 100nm 이하, 보다 바람직하게는, 90nm 이하, 더욱 바람직하게는 80nm 이하이다. 상기 평균 입자 지름의 상한이 100nm 이하인 것에 의해, 보존 안정성과 투명성이 보다 뛰어난 것이 된다.The average particle diameter of the bicell structure of the skin cosmetic composition of the present invention is not particularly limited, but is preferably 20 nm or more, more preferably 30 nm or more, still more preferably 40 nm or more. When the lower limit of the average particle diameter is 20 nm or more, a space for introducing the component G into the bicell structure can be secured. The upper limit of the average particle diameter is preferably 100 nm or less, more preferably 90 nm or less, still more preferably 80 nm or less. When the upper limit of the average particle diameter is 100 nm or less, storage stability and transparency become more excellent.
상기 평균 입자 지름(nm)의 측정은, 동적 광산란 광도계나 투과형 전자현미경(TEM)을 이용하여 행할 수 있다.The average particle diameter (nm) can be measured using a dynamic light scattering photometer or a transmission electron microscope (TEM).
본 발명의 피부 화장료용 조성물을 조제하려면, 상기 각 구성 성분을 혼합하고, 공지의 방법, 예를 들면 호모 믹서를 이용하여 교반함으로써 제조할 수 있다.In order to prepare the skin cosmetic composition of the present invention, it can be prepared by mixing the above components and stirring them using a known method, for example, a homomixer.
또, 본 발명의 피부 화장료용 조성물을, 피부 화장료에 사용되는 성분과 함께 혼합 등 함으로써, 화장수 등의 피부 화장료를 제조할 수 있다. 즉, 본 발명의 피부 화장료용 조성물은, 피부 화장료의 제조에 이용하는 원료(소위, 중간 원료)로 할 수 있다. 본 발명의 피부 화장료용 조성물을 이용함으로써, 수계나 저점도의 분산매에도 안정되게 분산시킬 수 있기 때문에, 성분 G를 피부 화장료 중에 배합시킬 수 있다. 또, 본 발명의 피부 화장료용 조성물은, 그 자체로 피부 화장료로서 사용할 수도 있다.Moreover, skin cosmetics, such as lotion, can be manufactured by mixing the composition for skin cosmetics of this invention with the component used for skin cosmetics. That is, the composition for skin cosmetics of the present invention can be used as a raw material (so-called intermediate raw material) used in the manufacture of skin cosmetics. Since the composition for skin cosmetics of the present invention can be stably dispersed even in an aqueous system or a low-viscosity dispersion medium, component G can be incorporated into skin cosmetics. Moreover, the composition for skin cosmetics of this invention can also be used as a skin cosmetic composition per se.
본 발명에 있어서는, 상기의 본 발명의 피부 화장료용 조성물을 함유하는 피부 화장료가 얻어진다. 또한, 본 명세서에 있어서는, 상기 「본 발명의 피부 화장료용 조성물을 함유하는 피부 화장료」를 「본 발명의 피부 화장료」라고 칭하는 경우가 있다. 본 발명의 피부 화장료 100 질량% 중의 본 발명의 피부 화장료용 조성물의 함유량은, 특별히 한정되지 않지만, 바람직하게는 0.1∼100 질량%, 보다 바람직하게는 0.5∼10.0 질량%로 할 수 있다.In the present invention, a skin cosmetic composition containing the composition for skin cosmetics of the present invention described above is obtained. In addition, in this specification, the said "skin cosmetic composition containing the composition for skin cosmetics of this invention" is sometimes called the "skin cosmetic composition of this invention." The content of the composition for skin cosmetic composition of the present invention in 100% by mass of the skin cosmetic composition of the present invention is not particularly limited, but is preferably 0.1 to 100% by mass, more preferably 0.5 to 10.0% by mass.
본 발명의 피부 화장료용 조성물(또는 피부 화장료)의 제형으로는, 특별히 한정되지 않지만, 예를 들면, 화장수(로션), 크림, 젤, 유액, 에어로졸 스프레이, 내추럴 스프레이, 스틱, 파우더, 롤 온, 시트(페이퍼) 등의 여러 가지 제형을 들 수 있다. 그 중에서도, 화장수(로션), 크림, 젤, 유액이 바람직하고, 화장수(로션)가 보다 바람직하다.The dosage form of the skin cosmetic composition (or skin cosmetic) of the present invention is not particularly limited, but for example, lotion (lotion), cream, gel, emulsion, aerosol spray, natural spray, stick, powder, roll-on, Various formulations, such as a sheet (paper), are mentioned. Among them, lotions (lotions), creams, gels, and emulsions are preferable, and lotions (lotions) are more preferable.
본 발명의 피부 화장료용 조성물(또는 피부 화장료)로는, 특별히 한정되지 않지만, 예를 들면, 보습 화장료, 미백 화장료, 여드름 케어용 화장료, 안티에이징 화장료(예를 들면, 주름 억제, 처짐 억제 등을 목적으로 함) 등의 스킨 케어 화장료; 두피 케어 화장료(예를 들면, 보습, 피지 억제 등을 목적으로 함); 데오도란트 화장료; 선블럭 화장료; 셰이빙 화장료; 보디용 세정료(예를 들면, 보디 샴푸, 고형 비누 등) 두피용 등을 들 수 있다. 그 중에서도, 본 발명의 피부 화장료용 조성물(또는 피부 화장료)은, 스킨 케어 화장료, 두피 케어 화장료인 것이 바람직하고, 스킨 케어 화장료인 것이 보다 바람직하다. 본 발명의 피부 화장료용 조성물(또는 피부 화장료)은, 예를 들면, 화장품, 의약부외품, 의약품, 잡화 중 어느 것이어도 된다.The composition for skin cosmetics (or skin cosmetics) of the present invention is not particularly limited, and examples thereof include moisturizing cosmetics, whitening cosmetics, acne care cosmetics, and anti-aging cosmetics (for example, for the purpose of suppressing wrinkles and sagging, etc.) referred to as) skin care cosmetics such as; scalp care cosmetics (for the purpose of, for example, moisturizing, sebum suppression, etc.); deodorant cosmetics; sunblock cosmetics; shaving cosmetics; Washing materials for the body (for example, body shampoo, solid soap, etc.), for the scalp, and the like are exemplified. Especially, it is preferable that the composition for skin cosmetics (or skin cosmetics) of this invention is a skin care cosmetic and scalp care cosmetics, and it is more preferable that it is a skin care cosmetic. The composition for skin cosmetics (or skin cosmetics) of the present invention may be, for example, any of cosmetics, quasi-drugs, pharmaceuticals, and miscellaneous goods.
본 발명의 피부 화장료용 조성물(또는 피부 화장료)을 적용하는 부위로는, 특별히 한정되지 않고, 얼굴(예를 들면, 이마, 눈가, 눈꼬리, 뺨, 입가 등), 팔, 팔꿈치, 손등, 손끝, 다리, 무릎, 발뒤꿈치, 목, 겨드랑이, 등(背), 두피 등을 들 수 있다.The site to which the composition for skin cosmetics (or skin cosmetics) of the present invention is applied is not particularly limited, and the face (eg, forehead, eyes, tails of eyes, cheeks, mouth, etc.), arms, elbows, backs of hands, fingertips, Examples include the legs, knees, heels, neck, armpits, back, and scalp.
본 발명의 피부 화장료용 조성물은, 물(성분 E)을 매체로 하는 피부 화장료 조성물에 있어서, 인지질(성분 A), 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스테롤 에테르 및/또는 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스타놀 에테르(성분 B), 분기쇄를 갖는 탄소수 12∼24의 1가의 지방족 알코올(성분 C), 프로필렌 글리콜, 디프로필렌 글리콜 및 1,3-부틸렌 글리콜로 이루어지는 군으로부터 선택된 1종 이상의 다가 알코올(성분 D), 스테롤(성분 F), 유분(성분 G), 옥시에틸렌의 평균 부가 몰수가 5∼30인 폴리옥시에틸렌 경화 피마자유(성분 H)를 포함한다. 본 발명의 피부 화장료용 조성물에 있어서의 바이셀 구조는, 성분 A를 중심으로 하여, 성분 B, 성분 C, 성분 F, 성분 G, 성분 H로 구성된다. 또 성분 D는, 제조 시에 있어서의 다른 성분의 용매로서 기능한다. 상기 각 성분의 역할은 완전하게는 해명되어 있지 않지만, 성분 B 및 성분 F, 성분 H가 지질 이분자막의 곡률을 조정하고, 성분 C가 지질 이분자막의 유연성에 기여하고 있다고 추정되는데, 바이셀 구조의 안정성이 특히 향상된다. 일반적으로, 성분 G를 배합하면, 바이셀 구조는 불안정화하는 경향이 있지만, 본 발명에 있어서는, 특히 성분 H를 지질 이분자막의 구성 성분으로서 포함함으로써, 지질 이분자막 내에 성분 G를 안정적으로 배합할 수 있는 것이 특징이다.The skin cosmetic composition of the present invention is a skin cosmetic composition using water (component E) as a medium, comprising phospholipid (component A), polyoxyethylene sterol ether having an average added mole number of oxyethylene of 15 to 50, and/or oxyethylene. Polyoxyethylene stanol ether (component B) having an average added mole number of ethylene of 15 to 50, a monohydric aliphatic alcohol having 12 to 24 carbon atoms having a branched chain (component C), propylene glycol, dipropylene glycol and 1,3- At least one polyhydric alcohol (component D) selected from the group consisting of butylene glycol, a sterol (component F), an oil component (component G), polyoxyethylene hydrogenated castor oil having an average added mole number of oxyethylene of 5 to 30 (component H ). The bicell structure in the skin cosmetic composition of the present invention is composed of component A, component B, component C, component F, component G, and component H, with component A as the center. In addition, component D functions as a solvent for other components at the time of production. Although the role of each component has not been completely elucidated, it is presumed that component B, component F, and component H adjust the curvature of the lipid bilayer membrane, and component C contributes to the flexibility of the lipid bilayer membrane, but the stability of the bicell structure. This is particularly improved. In general, blending of component G tends to destabilize the bicell structure, but in the present invention, in particular, by including component H as a component of the lipid bilayer membrane, component G can be stably incorporated into the lipid bilayer membrane. It is characterized by
본 발명의 피부 화장료용 조성물에 있어서의 바이셀 구조는, 미셀과 리포솜의 중간인, 20∼50nm 정도의 입경을 갖는다. 상기 바이셀 구조는, 지질 이분자막 내에 성분 G를 배합할 수 있기 때문에, 미셀보다도, 보다 많은 성분 G를 배합할 수 있다. 게다가, 리포솜 정도의 입경을 갖지 않기 때문에, 보존 안정성도 뛰어나다. 또, 상기 입경의 범위이면, 투명성도 손상되는 일이 없다.The bicell structure in the skin cosmetic composition of the present invention has a particle diameter of about 20 to 50 nm, which is intermediate between micelles and liposomes. Since the bicell structure can incorporate component G into the lipid bilayer membrane, more component G can be incorporated than micelles. In addition, since it does not have a particle size comparable to that of liposomes, it is also excellent in storage stability. Moreover, transparency is not impaired as long as it is the range of the said particle diameter.
이상의 메커니즘에 의해, 본 발명의 피부 화장료용 조성물은, 에몰리언트 효과를 갖는 유분을 포함하는 수계의 피부 화장료용 조성물이면서, 투명성 및 보존 안정성이 뛰어난 것으로 할 수 있다.According to the above mechanism, the composition for skin cosmetics of the present invention can be made excellent in transparency and storage stability while being an aqueous composition for skin cosmetics containing oil having an emollient effect.
실시예Example
이하에, 실시예에 의거하여 본 발명을 보다 상세하게 설명하지만, 본 발명은 이들 실시예로만 한정되는 것은 아니다. 또한, 표에 기재한 배합량은, 각 성분의 배합량(즉, 각 원료 중의 유효 성분의 배합량. 소위 순분(純分))이며, 특별히 기재하지 않는 한 「질량%」로 표시한다.Below, the present invention will be described in more detail based on examples, but the present invention is not limited only to these examples. In addition, the compounding quantity described in the table|surface is the compounding quantity of each component (ie, the compounding quantity of the active ingredient in each raw material, so-called pure part), and is expressed by "mass %" unless otherwise indicated.
실시예 1∼18, 비교예 1∼11Examples 1 to 18, Comparative Examples 1 to 11
표에 기록한 각 성분을 이용하여, 실시예 및 비교예의 각 피부 화장료용 조성물을 상법(常法)에 의해 조제했다.Using each component recorded in the table|surface, each skin cosmetic composition of the Example and the comparative example was prepared by the usual method.
표에 기재한 주된 성분은, 이하와 같다.The main components described in the tables are as follows.
수소 첨가 레시틴: 수소 첨가 대두 레시틴Hydrogenated Lecithin: Hydrogenated Soybean Lecithin
폴리옥시에틸렌 피토스타놀: 상품명 「NIKKOL BPSH-25」, 닛코 케미컬즈 가부시키가이샤 제조, POE-25 피토스타놀Polyoxyethylene Phytostanol: Trade name "NIKKOL BPSH-25", manufactured by Nikko Chemicals Co., Ltd., POE-25 Phytostanol
폴리옥시에틸렌 피토스테롤 A: 상품명 「NIKKOL BPS-20」, 닛코 케미컬즈 가부시키가이샤 제조, POE-20 피토스테롤Polyoxyethylene phytosterol A: trade name "NIKKOL BPS-20", manufactured by Nikko Chemicals Co., Ltd., POE-20 phytosterol
폴리옥시에틸렌 피토스테롤 B: 상품명 「NIKKOL BPS-30」, 닛코 케미컬즈 가부시키가이샤 제조, POE-30 피토스테롤Polyoxyethylene phytosterol B: trade name "NIKKOL BPS-30", manufactured by Nikko Chemicals Co., Ltd., POE-30 phytosterol
폴리옥시에틸렌 피토스테롤 C: 상품명 「NIKKOL BPS-5」, 닛코 케미컬즈 가부시키가이샤 제조, POE-5 피토스테롤Polyoxyethylene phytosterol C: trade name "NIKKOL BPS-5", manufactured by Nikko Chemicals Co., Ltd., POE-5 phytosterol
폴리옥시에틸렌 피토스테롤 D: 상품명 「NIKKOL BPS-10」, 닛코 케미컬즈 가부시키가이샤 제조, POE-10 피토스테롤Polyoxyethylene phytosterol D: trade name "NIKKOL BPS-10", manufactured by Nikko Chemicals Co., Ltd., POE-10 phytosterol
스테롤: 피토스테롤Sterols: Phytosterols
폴리옥시에틸렌 경화 피마자유 A: 상품명 「EMALEX HC-20」, 니혼 에멀전 가부시키가이샤 제조, PEG-20 수소 첨가 피마자유, HLB: 9.0Polyoxyethylene hydrogenated castor oil A: Trade name "EMALEX HC-20", manufactured by Nippon Emulsion Co., Ltd., PEG-20 hydrogenated castor oil, HLB: 9.0
폴리옥시에틸렌 경화 피마자유 B: 상품명 「브라우논 RCW-40」, 아오키 유시 고교 가부시키가이샤 제조, PEG-40 수소 첨가 피마자유, HLB: 12.5Polyoxyethylene hydrogenated castor oil B: Trade name "Brownon RCW-40", manufactured by Aoki Yushi Kogyo Co., Ltd., PEG-40 hydrogenated castor oil, HLB: 12.5
폴리옥시에틸렌 경화 피마자유 C: 상품명 「브라우논 RCW-50」, 아오키 유시 고교 가부시키가이샤 제조, PEG-50 수소 첨가 피마자유, HLB: 13.5Polyoxyethylene hydrogenated castor oil C: trade name "Brownon RCW-50", manufactured by Aoki Yushi Kogyo Co., Ltd., PEG-50 hydrogenated castor oil, HLB: 13.5
모노스테아린산 폴리에틸렌 글리콜: 상품명 「MYS-40V」, 닛코 케미컬즈 가부시키가이샤 제조, 스테아린산 PEG-40Polyethylene glycol monostearate: Trade name "MYS-40V", manufactured by Nikko Chemicals Co., Ltd., PEG-40 stearate
(평가)(evaluation)
실시예 및 비교예에서 얻어진 피부 화장료용 조성물에 대해서 이하와 같이 평가했다.The compositions for skin cosmetics obtained in Examples and Comparative Examples were evaluated as follows.
(1) 투명성(1) Transparency
조제 직후의 각 실시예 및 비교예의 피부 화장료용 조성물에 대해서, 육안 관찰을 행하였다. 결과, 모든 실시예는 투명했다.Visual observation was performed about the composition for skin cosmetics of each Example and Comparative Example immediately after preparation. As a result, all examples were transparent.
(2) 보존 안정성(5℃, 40℃)(2) Storage stability (5℃, 40℃)
각 실시예 및 비교예의 피부 화장료용 조성물 50g을 스크류관에 넣고, 5℃ 또는 40℃의 항온기 내에서 14일간 보존했다. 보존 후의 각 피부 화장료용 조성물의 스크류관의 외관을 육안로 관찰하고, 보존 안정성을 하기의 평가 기준에 따라 평가했다. 평가 결과는 표에 기재했다.50 g of the skin cosmetic composition of each Example and Comparative Example was placed in a screw tube and stored in a thermostat at 5°C or 40°C for 14 days. The external appearance of the screw tube of each skin cosmetic composition after storage was visually observed, and storage stability was evaluated according to the following evaluation criteria. The evaluation results are listed in the table.
<보존 안정성의 평가 기준><Evaluation criteria for storage stability>
○(양호): 분리, 석출물 또는 침전물이 전혀 인지되지 않는다.○ (good): Separation, precipitate, or precipitate was not recognized at all.
×(불량): 분리, 석출물 또는 침전물을 인지한다.× (defect): Recognize separation, precipitate or precipitate.
[표 1][Table 1]
[표 2][Table 2]
성분 A∼H를 함유하고, B/A치가 5.5∼18.0의 범위인 본 발명의 피부 화장료용 조성물(실시예)은, 모두 징명(澄明)한 외관을 보이고, 저온 보존(5℃), 고온 보존(40℃)하에서도, 분리, 석출물 또는 침전물이 전혀 인지되지 않았다. 즉, 본 발명의 피부 화장료용 조성물은 투명성이 뛰어나고, 저온 및 고온에서의 보존 안정성이 뛰어난 것을 알 수 있다.All of the skin cosmetic compositions (Examples) of the present invention containing components A to H and having a B/A value in the range of 5.5 to 18.0 show a clear appearance, and are stored at a low temperature (5°C) or at a high temperature. Even under (40° C.), no separation, precipitate or precipitate was recognized. That is, it can be seen that the skin cosmetic composition of the present invention has excellent transparency and excellent storage stability at low and high temperatures.
한편, 성분 A, B, F, H 중 어느 것을 결여하는 비교예의 피부 화장료용 조성물은, 저온 보존(5℃), 고온 보존(40℃) 중 어느 것에 있어서도, 분리, 석출물 또는 침전물이 인지되었다. 바이셀의 이분자막의 주요 구성 성분인 성분 A, B, 또는 F를 결여하는 비교예 1∼3에서는, 바이셀 구조 자체가 구성되지 않은 것으로 추측된다. 바이셀 구조의 안정화에 성분 H(특정의 옥시에틸렌의 부가 몰수를 갖는 폴리옥시에틸렌 경화 피마자유)가 기여하는바, 이것을 결여하는 비교예 4∼10은 바이셀 구조가 안정화되지 않아, 붕괴한 것으로 추측된다. 또 비교예 11은, B/A치가 본 발명에 규정된 범위 외인바, 저온 및 고온에서의 보존 안정성이 불량이 되었다.On the other hand, in the skin cosmetic composition of Comparative Examples lacking any of components A, B, F, and H, separation, precipitate, or precipitate was observed in either low-temperature storage (5° C.) or high-temperature storage (40° C.). In Comparative Examples 1 to 3 lacking components A, B, or F, which are the main constituents of the bimolecular film of the bicell, it is assumed that the bicell structure itself is not constituted. Component H (polyoxyethylene hydrogenated castor oil having a specific number of added moles of oxyethylene) contributes to the stabilization of the bicell structure, and Comparative Examples 4 to 10 lacking this contribute to the stabilization of the bicell structure, which is collapsed. guessed Further, in Comparative Example 11, since the B/A value was outside the range specified in the present invention, storage stability at low and high temperatures was poor.
또한, 본 발명의 피부 화장료용 조성물의 처방예를 나타낸다.In addition, the formulation example of the composition for skin cosmetics of this invention is shown.
〔처방예 1: 로션〕[Formulation Example 1: Lotion]
디프로필렌 글리콜 5.0 질량% Dipropylene glycol 5.0% by mass
글리세린 15.0 질량% Glycerin 15.0% by mass
트리(카프릴산/카프린산) 글리세릴 3.0 질량% Tri(caprylic acid/capric acid) glyceryl 3.0% by mass
스쿠알란 1.0 질량% Squalane = 1.0% by mass
세탄올 0.5 질량% Cetanol 0.5% by mass
폴리소르베이트 60 0.1 질량% Polysorbate 60 0.1% by mass
폴리소르베이트 65 0.1 질량% Polysorbate 65 0.1% by mass
디메티콘 1.0 질량% Dimethicone = 1.0% by mass
(아크릴레이트/아크릴산 알킬(C10-30))크로스폴리머 0.2 질량% (Acrylate/alkyl acrylate (C10-30)) crosspolymer 0.2% by mass
카르보머 0.07 질량% Carbomer 0.07 mass%
1,3-부틸렌 글리콜 0.08 질량% 1,3-butylene glycol 0.08% by mass
옥톡시글리세린 0.2 질량% Octoxyglycerin = 0.2% by mass
페녹시 에탄올 0.3 질량% Phenoxyethanol = 0.3% by mass
인산 세틸 0.1 질량% Cetyl Phosphate = 0.1% by mass
이성화당 1.0 질량% Isomerized sugar = 1.0% by mass
히알루론산나트륨 0.01 질량% Sodium hyaluronate = 0.01% by mass
가수분해 히알루론산 0.01 질량% Hydrolyzed hyaluronic acid = 0.01% by mass
아르기닌 0.4 질량% Arginine 0.4% by mass
에데트산2나트륨 0.05 질량% Disodium edetate = 0.05% by mass
바이오사카라이드검-1 0.01 질량% Biosaccharide gum-1 0.01% by mass
향료 0.05 질량% Flavoring agent 0.05% by mass
실시예 3의 피부 화장료용 조성물 5.0 질량% Composition for skin cosmetics of Example 3 = 5.0% by mass
정제수 잔부 Purified water ==========================
합계 100.0 질량% Total 100.0 mass%
〔처방예 2: 미용 유액〕[Formulation Example 2: Cosmetic Emulsion]
디프로필렌 글리콜 8.0 질량% Dipropylene glycol = 8.0% by mass
글리세린 2.0 질량% Glycerin = 2.0% by mass
이소스테아린산 프로필렌 글리콜 0.5 질량% Propylene glycol isostearic acid 0.5% by mass
수소 첨가 레시틴 0.5 질량% Hydrogenated lecithin = 0.5% by mass
올레인산 피토스테릴 0.1 질량% Phytosteryl oleate 0.1% by mass
(에틸헥산산/스테아린산/아디핀산) 글리세릴 0.5 질량% (Ethylhexanoic acid/stearic acid/adipic acid) Glyceryl 0.5% by mass
스테아린산 글리세릴 0.3 질량% Glyceryl stearate 0.3% by mass
이노시톨 0.4 질량% Inositol 0.4 mass%
옥타스테아린산 폴리글리세릴 1.0 질량% Polyglyceryl octastearate 1.0 mass%
옥테닐호박산 전분 알루미늄 0.2 질량% Octenylsuccinic acid starch aluminum 0.2% by mass
디메티콘 1.0 질량% Dimethicone = 1.0 mass%
베헤닐 알코올 1.0 질량% Behenyl alcohol = 1.0% by mass
베헨산 글리세릴 1.0 질량% Glyceryl behenate = 1.0% by mass
폴리소르베이트 60 0.7 질량% Polysorbate 60 0.7% by mass
미강 엑기스 0.1 질량% Rice bran extract = 0.1% by mass
카프릴릴 글리콜 0.3 질량% Caprylyl glycol 0.3% by mass
카르보머 0.25 질량% Carbomer = 0.25% by mass
옥톡시글리세린 0.05 질량% Octoxyglycerin = 0.05% by mass
마카데미아넛 지방산 피토스테릴 0.2 질량% Macadamia Nut Fatty Acid Phytosteryl 0.2% by mass
수산화칼륨 0.1 질량% Potassium hydroxide = 0.1% by mass
페녹시 에탄올 0.1 질량% Phenoxyethanol = 0.1% by mass
실시예 4의 피부 화장료용 조성물 10.0 질량% Composition for skin cosmetics of Example 4 10.0% by mass
정제수 잔부 Purified water = = = balance
합계 100.0 질량% Total 100.0 mass%
〔처방예 3: 시트 마스크〕[Prescription Example 3: Sheet Mask]
<화장료 조성물><Cosmetic composition>
폴리옥시에틸렌 경화 피마자유 0.3 질량% Polyoxyethylene hydrogenated castor oil 0.3% by mass
수산화 레시틴 0.5 질량% Hydroxylated lecithin 0.5% by mass
1,3-부틸렌 글리콜 5.0 질량% 1,3-butylene glycol 5.0% by mass
글리세린 5.0 질량% Glycerin = 5.0% by mass
말티톨 0.3 질량% Maltitol 0.3% by mass
소르비톨 0.2 질량% Sorbitol 0.2 mass%
히드록시에틸우레아 1.0 질량% Hydroxyethyl Urea 1.0% by mass
페녹시 에탄올 0.3 질량% Phenoxyethanol = 0.3% by mass
디프로필렌 글리콜 8.0 질량% Dipropylene glycol 8.0% by mass
폴리에틸렌 글리콜 4000 0.4 질량% Polyethylene glycol 4000 0.4% by mass
카르보머 0.08 질량% Carbomer = 0.08% by mass
크산탄검 0.1 질량% Xanthan gum 0.1% by mass
에데트산2나트륨 0.08 질량% Edetate disodium
가수분해 히알루론산 0.01 질량% Hydrolyzed hyaluronic acid 0.01 mass%
가수분해 콜라겐 0.05 질량% Hydrolyzed collagen 0.05 mass%
모란 엑기스 0.3 질량% Peony extract 0.3% by mass
무화과 엑기스 0.1 질량% Fig extract 0.1% by mass
로즈힙유 0.05 질량% Rosehip oil 0.05% by mass
옥톡시글리세린 0.05 질량% Octoxyglycerin 0.05% by mass
수산화칼륨 0.08 질량% Potassium hydroxide = 0.08% by mass
카프릴릴 글리콜 0.05 질량% Caprylyl glycol 0.05% by mass
폴리쿼터늄-51 0.01 질량% Polyquaternium-51 0.01% by mass
마카데미아넛 지방산 피토스테릴 0.01 질량% Macadamia nut fatty acid phytosteryl 0.01 mass%
(메타크릴산 글리세릴아미도에틸/메타크릴산 스테아릴)코폴리머 0.01 질량% (Glycerylamidoethyl methacrylate/stearyl methacrylate) copolymer 0.01% by mass
실시예 12의 피부 화장료용 조성물 1.0 질량% 1.0% by mass of the composition for skin cosmetics of Example 12
정제수 잔부 Purified water ==========================
합계 100.0 질량% Total = 100.0 % by mass
<시트 기재><sheet material>
부직포(합성 섬유 50%, 라이오셀 50%) 100.0 질량% Non-woven fabric (synthetic fiber 50%, lyocell 50%) 100.0 mass%
시트 기재 1.0 질량부에 대해, 화장료 조성물을 11.0 질량부 함침시켰다. 11.0 parts by mass of the cosmetic composition was impregnated with 1.0 parts by mass of the sheet substrate.
〔처방예 4: 젤 크림〕[Formulation Example 4: Gel Cream]
사카로미세스/쌀 발효액 10.0 질량% Saccharomyces/fermented rice liquid 10.0% by mass
트리옥타노인 3.0 질량% Trioctanoin = 3.0% by mass
디프로필렌 글리콜 8.0 질량% Dipropylene glycol 8.0% by mass
글리세린 5.0 질량% Glycerin = 5.0% by mass
스쿠알란 5.0 질량% Squalane 5.0% by mass
히드록시스테아린산 수소 첨가 피마자유 0.5 질량% Hydroxystearic acid hydrogenated castor oil 0.5% by mass
이소스테아린산 프로필렌 글리콜 0.5 질량% Propylene glycol isostearic acid 0.5% by mass
수소 첨가 레시틴 0.5 질량% Hydrogenated lecithin = 0.5% by mass
올레인산 피토스테릴 0.1 질량% Phytosteryl oleate 0.1% by mass
(아크릴레이트/메타크릴산 베헤네스-25)코폴리머 0.8 질량% (Acrylate/beheneth-25 methacrylate) copolymer 0.8% by mass
스테아린산 글리세릴 0.3 질량% Glyceryl stearate 0.3% by mass
이노시톨 0.4 질량% Inositol 0.4% by mass
옥타스테아린산 폴리글리세릴 0.3 질량% Polyglyceryl octastearate 0.3% by mass
미강 엑기스 0.2 질량% Rice bran extract 0.2 mass%
디메티콘 1.0 질량% Dimethicone = 1.0% by mass
베헤닐 알코올 1.0 질량% Behenyl alcohol 1.0 mass%
베헨산 글리세릴 0.3 질량% Glyceryl behenate 0.3 mass%
폴리소르베이트 60 0.7 질량% Polysorbate 60 0.7% by mass
미강 엑기스 0.1 질량% Rice bran extract 0.1% by mass
카프릴릴 글리콜 0.01 질량% Caprylyl glycol 0.01% by mass
카르보머 0.05 질량% Carbomer = 0.05% by mass
옥톡시글리세린 0.05 질량% Octoxyglycerin 0.05% by mass
마카데미아넛 지방산 피토스테릴 0.2 질량% Macadamia nut fatty acid phytosteryl 0.2% by mass
수산화칼륨 0.15 질량% Potassium hydroxide 0.15 mass%
페녹시 에탄올 0.1 질량% Phenoxyethanol 0.1 mass%
실시예 13의 피부 화장료용 조성물 20.0 질량% Composition for skin cosmetics of Example 13 = 20.0% by mass
정제수 잔부 Purified water balance
합계 100.0 질량% Total 100.0 Mass%
본 발명의 피부 화장료용 조성물에 의하면, 유분을 비교적 다량으로 포함할 수 있고, 또한 투명성 및 보존 안정성이 뛰어난 피부 화장료용 조성물을 제공할 수 있다.According to the composition for skin cosmetics of the present invention, it is possible to provide a composition for skin cosmetics that can contain a relatively large amount of oil and has excellent transparency and storage stability.
Claims (3)
성분 A: 인지질
성분 B: 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스테롤 에테르 또는 옥시에틸렌의 평균 부가 몰수가 15∼50인 폴리옥시에틸렌 스타놀 에테르, 또는 이 둘 다
성분 C: 분기쇄를 갖는 탄소수 12∼24의 1가의 지방족 알코올
성분 D: 프로필렌 글리콜, 디프로필렌 글리콜 및 1,3-부틸렌 글리콜로 이루어지는 군으로부터 선택된 1종 이상의 다가 알코올
성분 E: 물
성분 F: 스테롤
성분 G: 유분
성분 H: 옥시에틸렌의 평균 부가 몰수가 5∼30인 폴리옥시에틸렌 경화 피마자유.Component A below, component B below, component C below, component D below, component E below, component F below, component G below, component H below, and component B relative to component A. A composition for skin cosmetics having a mass ratio (B/A) of 5.5 to 18.0:
Component A: Phospholipids
Component B: polyoxyethylene sterol ethers having an average added mole number of oxyethylene of 15 to 50 or polyoxyethylene stanol ethers having an average added mole number of oxyethylene of 15 to 50, or both
Component C: branched chain monohydric aliphatic alcohol having 12 to 24 carbon atoms
Component D: at least one polyhydric alcohol selected from the group consisting of propylene glycol, dipropylene glycol and 1,3-butylene glycol
Ingredient E: Water
Ingredient F: Sterol
Ingredient G: Oil
Component H: Polyoxyethylene hydrogenated castor oil having an average added mole number of oxyethylene of 5 to 30.
추가로, 하기 성분 I를 함유하는 피부 화장료용 조성물:
성분 I: 글리세린 모노2-에틸헥실 에테르.According to claim 1,
Additionally, a composition for skin cosmetics containing the following component I:
Component I: Glycerin mono2-ethylhexyl ether.
추가로, 하기 성분 J를 함유하는 피부 화장료용 조성물:
성분 J: 탄소수 5∼10의 1,2-알칸디올.According to claim 1 or 2,
Additionally, a composition for skin cosmetics containing the following component J:
Component J: 1,2-alkanediol having 5 to 10 carbon atoms.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018185189 | 2018-09-28 | ||
JPJP-P-2018-185189 | 2018-09-28 | ||
PCT/JP2019/036973 WO2020066895A1 (en) | 2018-09-28 | 2019-09-20 | Skin cosmetic composition |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210015907A KR20210015907A (en) | 2021-02-10 |
KR102532929B1 true KR102532929B1 (en) | 2023-05-16 |
Family
ID=69951996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020207037364A Active KR102532929B1 (en) | 2018-09-28 | 2019-09-20 | Composition for skin cosmetics |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6982697B2 (en) |
KR (1) | KR102532929B1 (en) |
CN (1) | CN112351768A (en) |
WO (1) | WO2020066895A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022202880A1 (en) * | 2021-03-25 | 2022-09-29 | 株式会社カネカ | Lipid bilayer disc and method for producing same |
KR102618004B1 (en) * | 2023-03-28 | 2023-12-27 | (주)삼경코스텍 | Bicelle containing natural terpene glycoside with poorly water soluble active ingredient-stabilized and method for preparing the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010235491A (en) * | 2009-03-31 | 2010-10-21 | Nof Corp | Liposomes for cosmetics |
JP2018516588A (en) * | 2015-06-11 | 2018-06-28 | アーチャー−ダニエルズ−ミッドランド カンパニー | Lecithin compositions and methods of making and using such lecithin compositions |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05286824A (en) | 1992-04-08 | 1993-11-02 | Kanegafuchi Chem Ind Co Ltd | Liposome-containing cosmetic |
JPH11262653A (en) | 1998-03-17 | 1999-09-28 | Nof Corp | Oil-in-water type microemulsion and cosmetic containing tide same |
JP4406498B2 (en) * | 2000-07-10 | 2010-01-27 | ライオン株式会社 | Skin cosmetics |
JP2003267830A (en) * | 2002-03-15 | 2003-09-25 | Kose Corp | Liquid cosmetic |
ES2640164T3 (en) * | 2008-12-03 | 2017-11-02 | Shiseido Co., Ltd. | Oil-in-water cosmetic product |
JP5778908B2 (en) * | 2010-10-25 | 2015-09-16 | 株式会社ファンケル | Oil-in-water emulsion composition |
CN103079529B (en) * | 2010-10-29 | 2016-01-06 | 株式会社高丝 | Vesicle composition, containing its skin preparations for extenal use and cosmetics |
JP6114086B2 (en) * | 2013-03-28 | 2017-04-12 | 株式会社コーセー | Cosmetics |
JP6588568B2 (en) * | 2015-11-26 | 2019-10-09 | 株式会社コーセー | Composition containing bicell structure |
JP6887841B2 (en) * | 2016-03-29 | 2021-06-16 | 株式会社コーセー | Cosmetics |
WO2018061854A1 (en) * | 2016-09-28 | 2018-04-05 | 株式会社マンダム | Cosmetic composition |
-
2019
- 2019-09-20 KR KR1020207037364A patent/KR102532929B1/en active Active
- 2019-09-20 WO PCT/JP2019/036973 patent/WO2020066895A1/en active Application Filing
- 2019-09-20 CN CN201980043706.7A patent/CN112351768A/en active Pending
- 2019-09-20 JP JP2020549123A patent/JP6982697B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010235491A (en) * | 2009-03-31 | 2010-10-21 | Nof Corp | Liposomes for cosmetics |
JP2018516588A (en) * | 2015-06-11 | 2018-06-28 | アーチャー−ダニエルズ−ミッドランド カンパニー | Lecithin compositions and methods of making and using such lecithin compositions |
Also Published As
Publication number | Publication date |
---|---|
JPWO2020066895A1 (en) | 2021-04-01 |
WO2020066895A1 (en) | 2020-04-02 |
CN112351768A (en) | 2021-02-09 |
KR20210015907A (en) | 2021-02-10 |
JP6982697B2 (en) | 2021-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4397286B2 (en) | Oil-in-water emulsified cosmetic and method for producing the same | |
JP5072245B2 (en) | Oil-in-water emulsified cloudy skin cosmetic | |
US20210220234A1 (en) | Nano-Emulsion Cosmetic Composition In Which High Content Oils Are Stabilized | |
KR102367688B1 (en) | Transparent hair cosmetic composition | |
CN108697613B (en) | Cosmetic composition | |
US20250127705A1 (en) | Cosmetic compositions comprising a cyclodextrin having a particle size distribution | |
KR102532929B1 (en) | Composition for skin cosmetics | |
JP5623773B2 (en) | Oil-in-water emulsion composition | |
JP7682661B2 (en) | Oil-in-water emulsion composition | |
KR102381622B1 (en) | Stabilizing method of rice bran wax and cosmetic composition containing the stabilized rice bran wax | |
JP2017081895A (en) | Oil-in-water emulsion composition | |
JP6747763B2 (en) | Emulsified cosmetics | |
KR102759516B1 (en) | Cleansing composition | |
JP2019073462A (en) | Oil-in-water type emulsion skin cleanser | |
JP2011126821A (en) | Non-rinsing type hair cosmetic | |
EP3582746B1 (en) | Cosmetic lotion | |
JP2023152863A (en) | Skin cosmetic composition | |
JP2020147538A (en) | Milky lotion-like skin cosmetic | |
JP6632210B2 (en) | Masking composition | |
CN113825485B (en) | Improved quick-break water-in-oil emulsions | |
JP7546113B1 (en) | Oil-in-water emulsion cosmetics | |
JP2000007547A (en) | Cosmetic | |
JP7573995B2 (en) | Hair cosmetic composition | |
JP7309400B2 (en) | emulsified cosmetic composition | |
KR20180100641A (en) | Oil painting cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20201224 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20221128 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20230509 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20230511 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20230512 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |